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An accumulating evidence-base indicates that internalizing mental health disorders in 
adulthood are causally associated with cardiovascular diseases (CVD) and type-2 diabetes 
(T2DM). It is plausible, however, that the relationship between mental and cardiometabolic ill-
health becomes established long before adulthood, and that externalizing problems (the other 
central domain of common psychopathology) are also involved. These questions, as well as 
questions on the mechanisms that underlie the relationships, have been insufficiently investigated.  
The overarching goal of this dissertation was to expand current knowledge on how 
common mental health problems increase cardiometabolic risk over the life course.  
First, the prospective association between childhood internalizing (emotional problems) 
and externalizing problems (hyperactivity and conduct problems) with CVD and T2DM risk in 
adolescence was assessed in data from the Avon Longitudinal Study of Parents and Children 
(ALSPAC, N=7,730). Results showed that hyperactivity problems were associated with insulin 
resistance (high HOMA-IR); that hyperactivity and conduct problems were each associated with 
high triglyceride levels; and that emotional problems were inversely associated with high 
triglyceride levels.  These results suggest that childhood externalizing problems are an early life 
risk factor for CVD and T2DM and that childhood internalizing problems are not a risk factor or, 
		
that risk in these children does not become apparent until after adolescence.  
Second, the mechanisms underlying the prospective association of childhood hyperactivity 
and conduct problems with high levels of triglycerides in adolescence were investigated using 
causal mediation methods. Results showed that despite being associated with hyperactivity and 
with conduct problems, body mass index and lifestyle health behaviors including sleep, diet, 
physical activity, alcohol, and smoking, together these variables, as measured, mediated only 19.6 
% and 19.3% of the associations of hyperactivity and conduct problems with triglycerides, 
respectively. These results would suggest that mechanisms other than body adiposity and 
unhealthy behaviors are also involved and that those mechanisms have a larger role in mediating 
these relationships. Alternatively, it is possible that the observed small role of health behaviors is 
due to error in measurement and therefore improving measurements for health behaviors should 
be a central focus of future work.  
Third and last, a systematic review of the literature on the relationship between childhood 
externalizing problems with CVD and T2DM risk was conducted. Studies were graded for 
propensity to bias. Evidence was summarized and assessed for consistency.  Results strongly 
supported positive associations of externalizing problems with insulin resistance, T2DM, and with 
increased blood lipids among children and adolescents. Evidence suggested that associations are 
at least partly independent of body adiposity. Evidence provided mix support for the associations 
with T2DM and blood lipids in adults and with other outcomes in children or adults. Studies in 
children tended to be cross-sectional and to use valid and reliable assessment methods, whereas 
studies of adults tended to be prospective and to rely on less-valid, less reliable assessment 
methods. These results warrant more research, specifically prospective studies that track children 
into young adulthood, that employ well-validated measures of externalizing behaviors, that rely 
		
on repeated assessments of T2DM and CVD risk throughout follow-up, and that investigate 
mechanisms other than body adiposity and health behaviors. 
 Overall, this dissertation has found that childhood externalizing problems are 
prospectively associated with elevated CVD and T2DM risk, specifically with elevated risk of 
increased levels of blood lipids and insulin resistance. Unlike studies in adults, this dissertation 
does not support a role of internalizing problems as risk factors. Among children with externalizing 
problems, risk becomes evident before adolescence and appears to be largely driven by pathways 
independent of unhealthy behaviors and body adiposity. Implications of this research’s findings 
for health practice were proposed. This dissertation identified several gaps and methodological 
shortcoming in the extant literature. Recommendations were made for future research, including 
fundamental next questions to investigate, and study designs and methodologies that are best suited 
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Over the past decade, internalizing psychopathology diagnoses and behavioral 
symptomatology, including mood and anxiety disorders, have been singled-out as important 
contributors to the development and worsening of cardiovascular diseases (CVDs) and type-2 
diabetes mellitus (T2DM) among adults1-3. These mental health problems are highly prevalent. 
The National Comorbidity Survey (NCS-R) estimated the lifetime prevalence of anxiety disorders 
at 31 % and of mood disorders at 21 % in 2007. Prospective studies have shown associations of 
depression with incident coronary heart disease (CHD)1, stroke4, and T2DM5, of generalized 
anxiety with CHD2,6-9, and of post-traumatic stress disorder (PTSD) with incident ischemic heart 
disease (IHD)3, stroke3, and T2DM10.  
CVDs and T2DM continue to be major causes of morbidity and mortality, worldwide and 
in the US11, and these disorders and their biological precursors, once concentrated among older 
populations, are now increasingly diagnosed among the young12. Currently, only a fraction of 
CVDs and T2DM are explained by known risk factors and the identification of new risk factors is 
a top and explicit priority of public health and medical research12-14. 
Adults with depression, mood disorders, and other common psychopathology are much 
more likely than other adults to also have a positive life history of mental health problems starting 
in childhood15,16.  Cardiovascular and metabolic disorders have long latency periods, and their 
pathophysiological precursors are known to start developing early and have been described among 
young children17,18. Thus, it is plausible that the relationships of internalizing problems/disorders 
with CVDs, T2DM and their precursors, extensively described among adults, are ones that are 





A few studies that have examined and compared the roles of adolescence versus adult 
depressive symptoms in CVD development have shown that adolescence depressive symptoms 
influence adult CVD risk directly, that is, independently of their effect mediated by adult 
psychopathology19. These findings suggest not only that early life depressive symptomatology 
could be an independent CVD risk factor but also that these effects might become impervious to 
later improvements in mental health, underlying the importance of early detection of increased 
CVD risk and intervention among youth with behavioral problems.  
Furthermore, while the role of internalizing psychopathology in CVD/T2DM risk has been 
extensively investigated, at least among adults, it remains unknown whether externalizing 
psychopathology (or impulse-control disorders) might also play a role. This is a glaring current 
gap in the literature given that externalizing disorders such as Attention-deficit Hyperactivity 
Disorder (ADHD) and Conduct Disorder are already known risk factors of obesity20-23, itself a 
strong precursor of CVD/T2DM, and that ADHD and Conduct Disorder are the two most 
commonly diagnosed mental health problems in children. In a 2015-16 survey 9 % of US children 
aged 3-17 years had received an ADHD diagnosis, and among those children, as many as half were 
found to have additional behavioral or conduct problems24. 
In addition to this paucity of evidence there are at least four additional limitations in our 
understanding of these relationships. First, it is not clear whether internalizing and externalizing 
problems or disorders are both similarly associated with CVD/T2DM risk, or whether risk is 
associated to certain specific domains of psychopathology or symptomatology. Internalizing-
externalizing comorbidity is frequent in childhood and adolescence and very few studies have 




for clarifying who, among all youth with psycho-behavioral problems, might bear the highest 
CVD/T2DM risk, but also because knowledge of those distinctions could help shed important light 
into our still very poor understanding of the ways in which psychopathology brings about poor 
physical health.   
Second, it is unclear when, throughout the life course, these relationship/s become evident. 
The processes that lead to the development of cardiovascular disorders are usually long, and the 
emergence of clinical signs is normally preceded by years of asymptomatic, subclinical 
accumulation of biological insults. Biomedical research has demonstrated that biological 
precursors of CVD/T2DM can be found in children as young age 5.  Extensive evidence shows 
that early detection and intervention to stop these processes can have an impact in reducing 
morbidity and mortality, therefore identifying the developmental timing of the emergence of CVD 
and diabetes risk in children with internalizing/externalizing problems could therefore be critical 
for timely intervention.  
Third, it is unclear whether any of these relationships may vary by sex. Given that prior 
and recent research in adult samples has found sex differences in the relationships of depression 
and anxiety with CVDs and T2DM19,25, investigating in younger samples when such differences 
emerge is warranted. Identification of sex differences would help develop more valid estimates of 
effect sizes and would aid in the formulation of more efficient, sex-specific interventions to address 
risk.   
Fourth, it is also not known what mediates the relationships between 
internalizing/externalizing problems and CVD/T2DM risk. Two overarching theories are proposed 
in the literature. The first posits that through persistent high levels of stress psychopathology may 




include a cascade of neurochemical and neuroendocrine modifications that over time could lead to 
chronic high levels of inflammation and high levels of insulin. Chronic high levels of inflammation 
induce increases in blood lipids27. Persistent high insulin would, in turn, also lead to development 
of insulin resistance, and high levels of insulin and glucocorticoids are known to be key 
contributors to atherogenic processes in coronary arteries28. The alternative theory posits that 
stress-related psychopathology influences CVD/T2DM risk mainly by mechanisms involving 
unfavorable health behaviors26, specifically, behaviors known to increase CVD/T2DM risk 
through obesogenic effects --poor diet29, poor sleeping habits30, sedentary lifestyle20-- and by 
stress-coping, and sensation-seeking behaviors such as cigarette smoking, and alcohol use31.  
Identifying what the specific mechanisms are would contribute knowledge that could be 
critical in informing potential avenues for intervention by targeting of specific mediators but would 
also significantly strengthen the case of a causal link between these associations.  
Identifying whether the association/s are substantively independent of pathways that 
involve increased body adiposity could have significant implications for medical practice. By 
current clinical guidelines CVD/T2DM risk factors are assessed only among children/adolescents 
with diagnosed overweight/obesity. If the relationships between internalizing/ externalizing 
psychopathology and CVD/T2DM risk are only partially mediated by body adiposity then a sizable 
proportion of the children with these behavioral problems –those with body mass index within 








The overarching goal of this dissertation is to expand our current understanding of the role 
of childhood and adolescence externalizing and externalizing behavior problems/disorders in the 
development of CVD and T2DM risk over the life course. 
Specifically, I examine, whether childhood internalizing and externalizing behavior 
problems prospectively predict increased levels, in late adolescence, of 3 risk markers proven to 
be causally related to Ischemic heart disease, stroke, and T2DM  (aim 1); I assess, using causal 
mediation methods, the mechanisms underlying the prospective associations of childhood 
behavior problems with CVD/T2DM risk, estimating indirect effects (NIE) mediated by diet, 
sleep, physical activity, smoking, alcohol use and body mass index, as well as direct or no 
mediated- effects (NDE) (aim 2); and I conduct a systematic review of the extant literature that 
investigates the relationship of childhood externalizing disorders with increased CVD/T2DM 
throughout the life-course for evidence of associations, developmental timing of the emergence of 
risk,  and for evidence that these associations are, at least partially, independent of  increased body 
adiposity (aim 3). 
This dissertation is structured into 5 chapters. Chapter 1 features this introduction.  
Chapter 2 features research assessing aim 1, conducted using data from a large, 
prospective, UK-based birth cohort, the Avon Longitudinal Study of Parents and Children. I assess 
associations between children’s age 4 and age 7 internalizing problems (emotional problems) and 
externalizing problems (hyperactivity, and conduct problems) with clinically high levels of insulin 
resistance (HOMA-IR index), LDL-Cholesterol, and triglycerides.  These associations are 
examined in models that adjust different behavior problems for one another and also for a wide 
range of confounding factors including demographic, socioeconomic, maternal and environmental 




inverse probability of censoring weights to further control for attrition bias.  
Chapter 3 features research assessing aim 2. The mechanisms underlying associations 
identified by aim 1 research are examined. Using state of the art causal-mediation methods, indirect 
effects, defined as the effects that work through pathways involving health behaviors and BMI, 
and direct effects, defined as all other pathways not involving those mediators, are determined. 
The relative contribution of those pathways to the total effects of hyperactivity and conduct 
problems on triglycerides, are also estimated.  
Chapter 4 presents research that addresses aim 3, featuring a systematic review that 
assesses the existing literature for consistency with regards to three key questions: 1) What is the 
evidence of a positive association between childhood and/or adolescence externalizing 
behaviors/psychopathology and CVD/T2DM risk, 2) What is the developmental timing 
(childhood, adolescence, young adulthood, later in life) of the emergence of heightened risk, and 
3) What is the evidence and the degree to which the relationship/s are independent of body 
adiposity. 
Chapter 5 features the conclusions of this dissertation where results from chapters 2-4 are 
integrated and discussed in the context of existing research and the goals of this dissertation. 
Altogether, the research conducted in this dissertation could advance knowledge in several 
important fronts and have an impact on health practice.  Given that internalizing/externalizing 
psychopathology and cardiometabolic disorders are main drivers of global disease burden, 
unraveling whether and how they are causally linked since childhood could potentially open new 
avenues of intervention with, potentially, a sizable impact in life-course health and population 
disease burden. By directly exploring the role, in causal pathways, of factors that are modifiable, 




knowledge readily applicable to research on public health intervention. That mental and 
cardiometabolic ill-health are mainly linked through biological (i.e not through health behaviors) 
pathways is plausible and is a current research question with implications for prevention strategies. 
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Common psychopathological disorders, including depression and anxiety, are known risk 
factors of cardiovascular disease (CVD) and Type-2 Diabetes Mellitus (T2DM) in adults. Because 
cardiovascular and metabolic disorders have in general long latency periods and psychopathology 
tends to track from childhood into adulthood, it is possible that these relationships are established 
early in life, but very little research has examined these questions. Using data from a large British 
birth-cohort, the Avon Longitudinal Study of Parents and Children (ALSPAC, N=7,730), I 
examined the relationship between measures assessing internalizing and externalizing behavior 
problems -the two overarching domains of common childhood psychopathology- with elevated 
risk of CVD and diabetes in late adolescence. Using parents’ ratings of their children’s behavior 
at ages 4 and 7 (Strengths and Difficulties Questionnaire), I assessed whether externalizing 
problems  (hyperactivity and conduct problems subscales) and internalizing problems (emotional 
problems subscale) predicted the level of markers of CVD and T2DM risk: triglycerides > 130 
mg/dl, LDL-cholesterol > 130 mg/dl, and insulin resistance (Homeostasis model assessment of 
insulin resistance > 2.9, at age 17). After accounting for attrition bias and adjusting for 
demographic, socioeconomic, maternal factors, pregnancy and birth outcomes, and early 
childhood factors, I found positive associations of insulin resistance with hyperactivity (RR= 1.28, 
95% CI= 1.01-1.61); of high triglyceridemia with both hyperactivity (RR= 1.61, 95% CI=1.24-
2.09) and conduct problems (RR= 1.51, 95%CI= 1.20-1.90); and an inverse association of high 
triglyceridemia with emotional problems  (RR= 0.64, 95% CI= 0.42-0.97). This research suggests 
that childhood externalizing problems might be an early life risk factor for CVD and T2DM and 




cardiovascular and diabetes risk or, that risk in these children does not increase until after 
adolescence. More research is needed to confirm these findings and to determine mechanisms 







Adults with common psychopathology such as mood disorders, including depression and 
anxiety, are at an increased risk of CVD and T2DM1-10. Longitudinal studies have shown 
associations of depression with incident coronary heart disease (CHD)2-4, stroke10, and T2DM11, 
of generalized anxiety with CHD5-9, and of posttraumatic stress disorder (PTSD) with incident 
ischemic heart disease (IHD)12, stroke12, and diabetes13. Much less research, however, has 
investigated the role of common psychopathology in children on CVD/T2DM risk, beyond its 
association with body adiposity14. Common childhood psychopathology is linked to adult 
psychopathology15,16. Cardiovascular and metabolic diseases have in general long latency periods 
and their pathophysiological precursors are known to start developing during childhood17,18. 
Therefore, it is possible that the relationships between psychopathology and CVDs and T2DM, 
extensively described among adults, are ones that are established in early life.  
Within that framework, it is likely that at least some of the relationships thus far described 
between adult psychopathology and CVD/ T2DM risk could indeed be explained by a history of 
childhood psychopathology.  That is, it is plausible that childhood common psychopathology is a 
childhood risk factor with direct and indirect effects on adult CVD/T2DM risk, where the indirect 
effects are mediated, in part, by adult psychopathology. This hypothesis has found some support 
in a recent prospective, population-based study19 that estimated adult CVD risk in relation to 
psychological distress. The investigators found that psychological distress throughout the life 
course was associated with greater adult CVD risk. Specifically, they reported that, compared with 
CVD risk in participants with no history of psychological distress, CVD risk was the greatest 




followed by CVD risk among participants with childhood-only and adulthood-only psychological 
distress, in that order.  
In addition to a general paucity of evidence, there are at least three additional limitations 
in our understanding of the relationship between childhood behavior problems and CVD/T2DM 
risk. First, we don’t know when, in the life course, the relationship starts. Very few studies have 
examined CVD risk before adulthood and the very few studies that did either used cross-sectional 
designs20-25 or very small 21,23,25 and selected samples20-22, such as obese adolescents. This is an 
extant question in the current literature with critical implications for screening and primary 
prevention efforts. Second, we don’t know whether this is a general effect that cuts across all 
domains of psychopathology or whether this is one that pertains to only certain domain problems. 
Answering this question could bring important insight to our still poor understanding of the 
neurobiology26,27 underlying psychopathology28 and processes of biological embedding of 
psychopathology. Finally, it has never been examined whether these associations vary by sex.  
Given that prior and recent research in adult samples has found sex differences in the relationships 
of depression and anxiety with CVDs and T2DM, investigating in younger samples when such 
differences emerge is warranted. Identification of sex differences is important for two reasons: 
first, to obtain more valid estimates of effect sizes, and second, because we may gain important 
insight into still unknown sex divergences in pathobiological pathways. 
Very few prospective studies have examined CVD/T2DM risk before adulthood in 
relationship to childhood common psychopathology. In one large, longitudinal, population-based 
study14, boys with behavior problems throughout childhood had smaller –not larger- increases in 
blood pressure from childhood to adolescence. But, also in this study, behavior problems at age 14 




cholesterol (boys only), and higher triglycerides levels (boys and girls).   
Common psychopathology in childhood refers to a set of behavioral disturbances 
observable to parents and teachers that are broadly organized into two distinct domains, 
internalizing and externalizing behavior problems29-31. Internalizing behavior problems are 
manifested inwardly, and include depressive, anxious, and withdrawal symptomatology. 
Externalizing behavior problems are manifested outwardly, are characterized by poor self-
regulation and impulsivity and include hyperactivity, inattention, and antisocial and disruptive 
behaviors.  
In this study, I separately examine the longitudinal relationship of childhood internalizing 
and externalizing behavior problems, with CVD and T2DM risk in late adolescence. I assess CVD 
and T2DM risk using measures of biological precursors proven to be causally related to Ischemic 
heart disease, stroke, and T2DM: 1) insulin resistance (IR), 2) high triglyceridemia, and 3) elevated 
blood levels of LDL-cholesterol32,33. I assess for sex differences in the relationships and I examine 
the extent to which main effects are mediated by an effect of behavior problems on BMI in mid-
adolescence.  I examine these questions using a prospective study design and data from a large, 








Setting and participants  	
 The Avon Longitudinal Study of Parents and Children (ALSPAC) is a large, population-
based, cohort study in the UK34. The study recruited pregnant women in the Avon county of the 
Bristol area with expected due dates between April 1, 1990 and December 31, 1992. From those 
pregnancies, 13,978 children remained alive by year 1. From study initiation, 1990-92, to 2012, 
68 assessments had been administered in relation to the children (from birth to age 18), including 
25 child-based questionnaires, 34 child-completed questionnaires, and 9 clinical assessments 
(“Focus clinics”), starting at age 7.   Of the study core sample (n=13,978), 7,730 children had 
complete questionnaire data on internalizing and externalizing problems both at ages 4 and 7 years 
(exposure of interest) and constitute this study’s analytical sample. CM risk measures (study 
outcomes) were assessed at both the clinic visits at ages 15/16- and 17/18-years old. Some children 
attended both clinics and some children attended one of them. Age 17 assessments were used in 
these analyses whenever available (72% of the children) and age 15 measures were used otherwise 
(28%). Out of 7,730 children in the analytical sample, n=3,422 (44%), had available measures of 
fasting insulin and glucose, and n= 3,446 (45%) had available measures of blood lipids. To account 
for possible biases created by this follow-up attrition all analyses are adjusted by inverse 
probability of censoring weights (IPCW), whereby each participant was assigned a weight 
corresponding to the probability of that participant remaining in the study based on her/his 
exposure (behavior problems), and covariates status. A comparison of variables distribution 
between participants retained and lost to follow-up is shown in the appendix tables, A.2.1 and 




to have an externalizing problem, come from households with lower income, and have mothers of 




Internalizing and externalizing behavior problems 
 
 
Behavior problems in the participants were assessed using the parent version of the 
Strengths and Difficulties (S&D) questionnaire35 completed by the mothers or main caregivers at 
participant’s ages 4 and 7 years. The S&D is one of the most widely used short questionnaires for 
the evaluation of child mental health problems in epidemiological samples in children aged 4-16 
years of a wide range of socio-economic status. It consists of 25 items (each querying on a specific 
behavior) organized into 5 subscales, two assessing internalizing behaviors (“emotional problems” 
and “peer problems”), two assessing externalizing problems (“hyperactivity problems” and 
“conduct problems”) and a last one not assessing a behavior problem. Parents rated their child’s 
behavior over the past 6 months on a 3-point scale: Not true, Somewhat true, and Certainly true.  
The total difficulties score (sum of scores from the four subscales that indicate a difficulty) is 
considered a valid measure of overall child psychopathology35. The score correlates well with 
interview measures, differentiates clinical from community samples, and correlates with clinician-
rated and diagnosed behavioral psychopathology. Reliability of the S&D scale was deemed 
satisfactory when assessed in a nationally representative sample of British children aged 5-15 
years, N=10,438, with mean Cronbach’s alpha across subscales equal to 0.73, and mean test-retest 
reliability after 4-6 months across subscales equal to 0.6236.  




true, and 2=Certainly true. Five items are reverse coded. Scores for each of the subscales are 
obtained by summing the scores of each of the 5 items that make up the subscale. Scores for 
subscales have therefore a range 0-10. Cut-off points for each of the four subscales of behavior 
problems have been defined using a large, representative sample of British children. For each 
subscale, the cut-off points divide the categories “Close to average” (bottom 80%), “Slightly 
raised” (10%), “High”, (5%) and “Very high” (5%)37. For these analyses, I created four binary 
variables, 1) Ever emotional problems, 2) Ever peer problems, 3) Ever hyperactivity problems, 
and 4) Ever conduct problems, each reflecting whether the specific behavior problem was present 
(high or very high scores, based on above defined categories) at either age 4 or age 7 assessments.  
 
Cardiovascular and T2DM risk markers 
Study participants provided fasting blood samples at one, or both, of 15/16-years old clinic 
visit and the 17/18-years old clinic visit. Teens were instructed to fast overnight if attending the 
clinic in the morning or for 6 hours at least if attending after lunch. Blood samples were processed 
immediately after collection and plasma was frozen at −80oC until assay time, between three to 
nine months later, with no freeze-thaw cycles in between. A modified version of the standard Lipid 
Research Clinics Protocol that employs enzymatic reagents was used to determine blood lipid 
concentrations (total cholesterol [Total-C], high density lipoprotein cholesterol [HDL-C], and 
triglycerides). LDL-C was determined from these by applying the Friedwald formula: LDL-C = 
Total-C – HDL-C + Triglycerides x 0.45. Insulin was measured by means of ELISA (Enzyme 
linked immunosorbent assay; Menodia, Uppsala, Sweden) that did not cross-react with proinsulin. 
Glucose was measured using an automated procedure. Insulin resistance was estimated using the 




been used extensively. It has been validated against gold-standard methods including the 
hyperinsulinemic- euglycemic clamp38. HOMA-IR is calculated as: fasting insulin [uU /mL] x 
fasting glucose [mmol /L] / 22.5.  Currently, there is no consensus on a cut-off point to define high 
values of HOMA-IR in adolescents; therefore, for analyses, HOMA-IR was dichotomized at the 
85th percentile point for the sample distribution, corresponding to an index value of 2.9. This study-
specific cut-off choice is supported by a recent study of 667 healthy Chilean adolescents, in which 
a value of HOMA-IR of 2.6 (84th percentile point of the sample distribution) was identified as the 
optimal cut-off point for diagnosis of the Metabolic Syndrome, by ROC analysis39.  The positive 
relationship of blood levels of LDL-C and of triglycerides33,40,41 with risk of coronary heart disease 
and other cardiovascular outcomes have been very well documented. Both markers are routinely 
assessed in the clinical setting as indicators of elevated cardiovascular risk among healthy adults. 
For these analyses, both LDL-C and triglycerides were dichotomized as “High” (³ 130 mg/dl) 
versus “Not high” (< 130 mg/dl), as recommended by the National Health of Blood and Lung 
Institute Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in 
Children and Adolescents42, 2012, for children ages 10-19 years. Height and weight were assessed 
at the clinic visit at age 15/16, with children wearing light clothes and no shoes. Weight was 
assessed using Tanita scales and was recorded to the nearest 0.1 kg43 and height was assessed with 
a Harpender stadiometer and recorded to the nearest 0.1 cm. BMI was calculated as weight (kg)/ 
height (cm) 2 and for analysis BMI was dichotomized around the CDC-estimated 95th percentile 
point of BMI for sex and age (in months) that separates obese and non-obese children. 
 
Study covariates 




assessment of behavior problems. Most Information was collected by means of mother-completed 
questionnaires or was extracted from routine antenatal medical records of mothers who granted 
access to the records. Information reported by mothers through questionnaires during pregnancy 
included: child’s ethnicity (White/Caucasian or other), maternal highest educational attainment 
(Below O-level=less than high school diploma, O-level =high school diploma, A-level = post high-
school education), number of previous pregnancies, whether mother’s biological parents had any 
of diabetes (Yes, No), hypertension  (Yes, No), and heart disease (Yes, No). Information collected 
from the mothers by questionnaire after birth and before child’s age 4 included: maternal diagnosis 
of diabetes (never, ever, during pregnancy only), breastfeeding, (never, < 3 months, 3-5 months, 
6+ months), maternal depression  (Assessed by the Edinburgh Post Natal Depression Scale, 
previously validated in ALSPAC; the total score was used in these analyses); household weekly 
income (less than £100,  £100-199, £200-299, £300-399 and £400+), and neighborhood stress. The 
neighborhood stress index (0-22) was determined based on mother’s answers to 11 questions about 
housing and neighborhood conditions.  Information extracted from antenatal medical records 
included: maternal age at delivery, gestational hypertension (Yes, No), and weight gain through 
pregnancy (less than, recommended, or above recommended, according to Institute of Medicine 
recommendations for weight gain in pregnancy based on the mother’s weight before pregnancy), 
maternal diagnosis of diabetes (never, before pregnancy, during pregnancy). Measures of birth 
weight and gestational age were also extracted from these records and used to derive birth-outcome 
variables: “Preterm, Yes/No” (defined around the CDC-defined cut-off point of 37 weeks), 
“Small-for-gestational-age (SGA)”, Yes/No, and “Large-for-gestational-age (LGA)”, Yes/No, 
based on CDC-provided cut-offs points of birth weight (in grams) for gestational age (in weeks). 




child behavior problems or CM risk.  
 
Missing covariate information 
 
The proportion of missing covariate information was typically below 5% and was the 
greatest for family income at 13%. Missing covariate information was assumed to be at random 
and was imputed using IVEware software. The software was developed following the 
implementation44 of the multiple imputation framework which uses a Bayesian approach for 
estimating missing values. Inferences resulting from analyses run separately in each of the imputed 
datasets (5) were combined to produce summary effect measures and covariance matrixes with 
SAS proc mianalize.  
 
Censoring weights 
Approximately 55% of the cohort left the study between recruitment and the year 2012. To 
account for possible biases due to study attrition over the 10-year follow-up, analyses were 
adjusted using inverse probability of censoring weights (IPCW)45. Separate sets of stabilized 
censoring weights (SCW) were estimated for different study sub-samples for the different study 
outcomes (insulin resistance, triglycerides, and LDL-C). Weights were estimated as follows: for 
each study outcome I created a binary variable to indicate censoring (0=Outcome information 
available, 1=No outcome information available). I fitted logistic regression models to estimate the 
unconditional and conditional probabilities of remaining uncensored (C=0) using behavior 
problem variables and study covariates as predictors of censoring status. SCW were calculated as: 
= P (C=0) /P (C=0 | E, Cov), where “E” represents eight variables reflecting the status (Yes, No) 




represents all study covariates assessed before age 4. In each of the estimated SCW sets, the mean 




I first examined whether ever having a behavior problem –hyperactivity, conduct, 
emotional, or emotional problems- was associated with the study outcomes using Chi-Square tests. 
I then calculated the relative risk associated with each behavior problem for each outcome in 
multivariate log-linear regression models, separately for each behavior problems. Models were 
progressively adjusted for confounding using the same general strategy for all outcomes, though 
the actual covariates included varied slightly across outcomes as not all covariates were found to 
confound the main effects of all the outcomes. Covariates were considered confounders and were 
kept in the models if, when introduced to the models, the observed change in the beta coefficient 
associated with the main effect was of 10 % or more.  In Model 1 I adjusted for sex and race, 
model 2 added additional demographics, maternal characteristics, and family history of CM 
disorders, and model 3 added pregnancy and gestation-level covariates, birth outcomes, and 
breastfeeding. To determine whether the effects of behavior problems on CM risk markers varied 
by sex an additional model (Model 3b) added the sex*behavior problems effect modification term 
to the fully adjusted model 3. In model 4, to examine whether the effects of behavior problems on 
CM risk were explained by an effect of the behavior problems on obesity, which in turn influenced 
CM risk at age 17, I added obesity at age 15 to the fully adjusted Model 3. In this stage, when I 
found that a main effect was reduced upon further adjustment of the model for BMI, I interpreted 




behavior problems with the CM risk marker at age 17. This interpretation of regression results 
requires the absence of statistical interaction between the variable for the behavior problems and 
the BMI variable. I assessed the presence of such interactions (I had adequate power), using a 0.10 
significance level.  No interactions were detected. All tests conducted in these analyses, including 
bivariate association tests and regression models, are adjusted by means of IPCW to account for 
the effects of participant attrition through study follow-up. All statistical analyses were conducted 








Description of the cohort  
The distribution of study variables among participants is shown in table 2.1.  In this study 
sample, 11% of the participants had hyperactivity problems at ages 4, 7, or at both ages, while 
17% had conduct problems, and 9% had emotional problems.  Among these children, 15% went 
on to have a HOMA-IR index above 2.92 in late adolescence, while 3% of them had fasting LDL-
C levels above 130 mg/dl, and 11 % of them had triglyceride levels above 130 mg/dl.  
 
Behavior problems and outcomes 
In bivariate analyses that assessed crude associations between each behavior problem and 
the study outcomes (Table 2.1), hyperactivity problems were associated with high HOMA-IR 
index (13.9% versus 10.1%, p= 0.01), and with high triglycerides (16.4% versus 9.9%, p <0.00). 
Conduct problems were associated with high HOMA-IR index value (19.1% versus 16.2%, p= 
0.10), and were associated with high triglycerides (23.3% versus 16.0%, p < 0.00). Emotional 
problems were not associated with high HOMA-IR index value, or with high LDL-C, but were 
negatively associated with high triglycerides (5.8% versus 9.1%, p= 0.04). PPs were not associated 
with any study outcomes.  
Bivariate tests also showed that hyperactivity and conduct problems were positively 
associated with obesity at age 15 (hyperactivity: 15.4% versus 11.4%, p= 0.020; conduct problems: 
25.3% versus 18.0%, p< 0.001), while emotional problems were not associated with obesity 




predictor of high HOMA-IR index 15.8% versus 3.1%, p<001, high LDL-C (11.8% versus 3.6%, 
p<.001), and high triglycerides (16.7% versus 4.0%, p<.001 (Table 2.1).  
In multivariate log-linear regression models that estimated the relative risk for the study 
outcomes associated with each behavior problems (Ever behavior problem versus Never behavior 
problem), progressively adjusting for demographic, familiar and maternal risk factors of 
cardiovascular and diabetes risk, maternal mental health, pregnancy and birth outcomes, and early-
childhood confounder variables, high HOMA-IR index and high triglycerides remained associated 
with hyperactivity problems (high HOMA-IR index, RR=1.28, 95% CI= 1.01 – 1.61, Table 2.2;  
high triglycerides levels, RR=1.61, 95% CI= 1.24 – 2.09, Table 2.4), and high triglycerides 
remained associated with conduct problems (RR=1.51, 95% CI= 1.20 – 1.90, Table 2.4) and were 
negatively associated with emotional problems (RR=0.66, 95% CI= 0.42 – 0.99, Table 2.4). There 
were no associations of high LDL-C with any behavior problems after confounder adjustment 
(Table 2.3). I did not find statistical evidence of sex differences in the associations of study 
outcomes with behavior problems (Tables 2.2-2.4).  Further adjustment of full-models by 
adolescence BMI led to only minimal reductions in the estimations of effect size. 
To rule out the possibility that the differences in triglycerides and LDL-C levels between 
children with and without behavior problems observed at the end of follow-up could have already 
been present at start of study follow-up, a secondary analysis (not shown) was conducted on a 
subset of children (N= 2353) for whom measures of non-fasting lipids were available from the 
clinic at age 7 (study baseline point).  Neither the levels of triglycerides nor LDL-C levels at age 
7 were associated with any of the behavior problems assessed.  
In sensitivity analysis I further adjusted models for use of oral contraceptives, which are 




use between girls with and without behavior problems. Adjusting models for contraceptive use did 




I studied whether externalizing and internalizing problems in childhood predicted elevated 
CVD and T2DM risk, the latter indicated by clinically significant levels of three biological 
precursors of these outcomes –high triglycerides, high LDL-Cholesterol, and insulin resistance- in 
late adolescence, using a large, population-based sample. I found positive associations of 
externalizing problems with insulin resistance and triglycerides, and null or inverse associations 
of internalizing problems with these outcomes. Some of the associations, which were notably 
stronger for triglycerides, persisted after adjustment for demographic, socioeconomic, maternal 
and environmental factors, family history of CVD and T2DM, pregnancy and birth outcomes, and 
breastfeeding.  The association was also evident when I examined triglyceride levels as a 
continuous outcome (results not shown). In fully adjusted models, hyperactivity was associated 
with an 8% increase in triglycerides (p < .01) while conduct problems were associated with a 5% 
increase (p < .01). I did not find evidence of sex differences in the associations examined and 
found that obesity at age 15 only minimally explained the relationships between externalizing 
problems and the study outcomes at age 17. To my knowledge, this is one of the first studies to 
prospectively examine both internalizing and externalizing problems in relation to CVD and 
T2DM precursors, other than body adiposity, before adulthood.  
The positive associations of externalizing problems with insulin resistance and 




before, but are consistent with findings, in a community sample, of cross-sectional positive 
associations of CBCL-aggressive behavior scores at age 14 with higher triglycerides (in boys and 
girls) and with higher HOMA-IR values (in girls only). The positive association of externalizing 
problems with obesity has however been described quite extensively, mostly among adults46-48, 
but also in children31,46-48, and is summarized in systematic reviews and meta-analyses49. Our 
findings are largely consistent with that research. For example, a cross-sectional positive 
association of externalizing problems with obesity was found in a community-based, study of 5-
year old children31.  In another study ADHD at age 10 was associated with BMI at age 1448, while 
in another prospective study, hyperactivity and conduct problems at age 5 did not associate with 
BMI at age 10 (appraised by mothers) but predicted higher BMI at age 30.  
My results in relation to internalizing problems are less consistent with the current 
literature. The finding of a null association between emotional problems and insulin resistance in 
both sexes contradicts the reported positive association of depression with insulin resistance and 
with incident diabetes reported in studies of adults,11,50,51 an association that also appears to be 
limited to women26,27. However, there are fewer studies that have examined the relationship among 
children, and there is less consistency14,18,22,52,53 among these studies. Of five prior studies, just one 
used a prospective design and a community sample54, and that study found, like I did, a null 
association of depressive symptoms with insulin resistance. The other four studies14,24,52 reported 
positive associations but, three of these studies were cross-sectional, and the fourth was a 
longitudinal study20 of overweight or obese children with high HOMA values at baseline. It is 
possible that depression is prospectively associated with insulin resistance, but the relationship is 
one that does not develop before adulthood. Among children, insulin resistance almost always 




symptoms subsequent to perception of peer rejection or social stigma related to their excess weight, 
which would explain the positive association reported by all cross-sectional studies and by the 
longitudinal study of overweight/obese children who had high levels of HOMA-IR index at 
baseline. 
My finding of an inverse association of internalizing problems with triglycerides in 
adolescence is also novel, as no other studies have examined this relationship in childhood using 
a longitudinal design. The result seems at odds with the extended literature that has examined the 
relationship of depression and CVD/T2DM risk factors in samples of adults53. The finding is, 
nevertheless, internally consistent with my other observation of an inverse association of 
internalizing problems with obesity. The literature that delves into this relationship among children 
is, however, sparse, and quite inconsistent, with some studies finding, like us, inverse associations.  
For example, a study that reported a positive14, cross-sectional association of depressive symptoms 
with triglycerides at age 14, also found a prospective inverse association of depressive symptoms 
at age 5 with systolic blood pressure at age 14, the latter examined using a prospective design and 
follow-up similar to ours. Both those study’s observations were apparent only among boys.  
My finding of an inverse association of internalizing problems with obesity is also at odds 
with the widely reported positive association observed among adults (likely, mostly among 
women) but it is in agreement with at least two prior studies in children. In one of them that, like 
us, examined a large population-based British sample, the British Cohort Study46, emotional 
problems at age 5 were inversely associated with obesity at age 10. The other study, by Suglia et 
al.31, observed, in a large community sample of children of age 5, a cross-sectional negative 
association of internalizing problems with obesity (the association was negative among boys and 




make sense in light of research showing that while depression is associated with increased eating 
(one of the key drivers of obesity) among adults, in children, depressive symptoms are associated 
with appetite suppression55,56.  
Although I observed, as expected, sex differences in the prevalence of behavior problems 
and of high LDL-C, I did not find statistical evidence of sex differences in any of the associations 
examined. It is possible that sex differences in these associations become statistically different 
after adolescence.  
Together, the evidence from our study and prior studies seem to suggest that the nature of 
the relationship of depression/depressive symptoms and obesity and CVD/T2DM risk might be a 
complex one, one that may change direction over the life course, and with changes operating 
differently across the sexes. Even though the number of studies among youth is still small, the 
evidence seems to indicate that while depression and depressive symptoms positively predict 
obesity and higher CVD and T2DM risk in adult women, the relationship could be null or inverse 
in childhood, with unclear sex differences before adulthood. 
Several mechanisms could underlie the associations reported in this study. Although 
current empirical evidence is insufficient, it is speculated, as briefly mentioned above, that at least 
some of these associations are driven by an effect of behavior problems on diet and eating 
behaviors. Externalizing problems are associated with greater impulsivity, and low inhibitory 
control and self-regulation. Impulsiveness may lead to binge eating. Higher-than expected rates of 
binge eating have been observed in ADHD57,58. Impulsiveness and lack of self-control may 
promote the ingestion of large quantities of comfort foods59, including sugar-sweetened beverages 
and junk food with high content of trans-fats, both linked with increased CVD/T2DM risk through 




other hand, been associated, among children, with appetite suppression, which would be consistent 
with the inverse association found for emotional problems with obesity and triglycerides. 
The associations of behavior problems with high HOMA-IR index and with high 
triglycerides were incompletely explained by an effect of behavior problems on BMI, suggesting 
the existence of direct and/or alternative, indirect pathways. Impulsiveness has been shown to 
increase triglyceride levels, independently of BMI60. Sleep disturbances have been shown to 
negatively affect cardiovascular risk and to do so only in part by influencing BMI. It is possible 
that different sleep disturbances associated with externalizing61,62 and internalizing behavior 
problems–with reduced sleeping associated with externalizing, and increased sleeping associated 
with internalizing problems- could explain some of the associations reported by this study. 
Physical activity is another factor known to be related to behavior problems in children that could 
impact CVD and T2DM risk directly and indirectly through BMI. Tobacco smoking is yet another 
mechanism possibly involved in these relationships. Smoking is associated with elevated levels of 
triglycerides, in both sexes, particularly in males63,64. On the other hand, childhood externalizing 
problems have been shown to be positively, while internalizing problems are inversely associated 
with smoking in adolescence65. Therefore, smoking could explain the positive and inverse 
relationships found for externalizing and internalizing problems respectively with triglycerides. 
Finally, mechanisms other than health behaviors could be involved as well. 
This study had a number of limitations. First, as in most longitudinal studies, this study 
suffered from participant attrition; we lost approximately 50 percent of children over the 10-year 
follow-up period. However, we addressed this by using IPCW to account for at least some of the 
bias that may have been created by attrition.   




rather than on clinical interview diagnosis, which is considered the gold standard for assessment.  
In fact, it is possible that the negative association that I, and others, have found for internalizing 
problems and some study outcomes could be the result of error in the assessment of internalizing 
symptoms. It has been observed by others that findings involving internalizing problems in young 
children tend to be less consistent than findings involving externalizing problems, and it has been 
proposed that this could result from young children’s difficulties with expressing emotions and 
their parents’ difficulties with correctly understanding those expressions and withdrawal behaviors 
in general66. However, such assessment errors would be expected to bias an effect size to -and not 
away- from the null, as I have observed for some of the relationships examined.  An alternative 
explanation could be that parents of children with less-than-average appetite and lower BMI are 
more likely to interpret the lack of appetite as an indication of emotional problems in the child 
(reverse causation). This seems unlikely, however, as the scales have been extensively validated 
and the cut-off points that I used have been determined against clinical interview diagnosis in a 
large, sample of British children –as was this study’s sample- and cut-offs were deemed 
appropriate for children ages 4-16.  
Third, I did not have baseline measures of one of the study outcomes, HOMA-IR index, 
and had baseline triglycerides and LDL-C measures for a fraction of participants; therefore, it is 
possible that differences observed at age 17 were already present at baseline. However, this is 
unlikely given the young age of the children at baseline, the long follow-up period, and 
particularly, because baseline triglycerides and LDL-C levels did not vary by behavior problem 
status among the 68% for whom those measures were available. As in every observational study, 
this study may suffer from residual confounding bias due to unmeasured confounders, or error in 




such as methylphenidate, which some of the children with externalizing disorders may have been 
using. These drugs have been shown to reduce levels of triglycerides67, therefore, our results are 
biased to the null and our effect estimates are conservative. It’s been reported that approximately 
0.2 % of the UK population of children aged 15-19 y used methylphenidate in the year 2005, when 
this study’s outcomes were assessed, and the percent doubled by year 2012. In the US, 3.3 % of 
children in that age group67 used methylphenidate in 2012. The relationship of externalizing 
problems with triglycerides might vary across countries with different prevalence of 
methylphenidate use.  
This study examined only three of the most relevant precursors of CVD and T2DM and 
these results now warrant extending this research to investigate other key cardiometabolic 
outcomes including blood pressure, carotid atherosclerosis, and others. A few prior studies that 
have examined the association of behavior problems with blood pressure in pediatric samples 68-71 
have found null associations 69-70 or associations that suggest a protective effect of behavior 
problems 68,71. Those relationships appear to be stronger among boys, and in particular among boys 
with more severe externalizing symptoms.  Future studies that investigate blood pressure in 
relation to childhood behavior problems should use study designs that are appropriate to assess 
and disentangle the roles of these factors. 
The associations I estimated are only moderate in size, but these effects could contribute 
to overall population burden of chronic diseases significantly given the high prevalence of 
externalizing problems and considering that I assessed early effects but these relationships are 
thought to operate through cumulative effects over the life course leading to significantly higher 




The sample of this analysis was overwhelmingly white and more affluent than the source 
population, and therefore the findings reported here might not be generalizable to other 
populations.  
This study also has important advantages. First, it draws from a large and well-established 
birth-cohort known for the quality and completeness of its measures and intensive follow-up. 
Second, like only very few prior studies have done, I was able to examine longitudinal effects of 
both dimensions of childhood behavioral psychopathology. Third, by relying on two separate 
assessments of children’s behavior problems I was able to identify both, childhood early and later 
onset cases. Fourth, I was able to adjust for confounding in a more comprehensive way than most 
other studies, including maternal and pregnancy level factors, birth outcomes, and childhood 
factors known to associate strongly to study outcomes, such as breastfeeding.  
More studies are needed to confirm these results, to examine the relationships of childhood 
behavior problems with other relevant CVD/T2DM precursors, and to determine the mechanisms 
explaining the associations reported, including the role of diet and eating behaviors, sleeping 
patterns, physical activity, smoking in early adolescence, and pathways other than health 
behaviors, for example those involving neurochemical modifications of the hypothalamus/HPA-
axis.  Future studies should attempt to clarify the apparent opposite effects of childhood and 
adulthood depressive symptoms by using designs with longer follow-up periods and repeated 
assessment of psychopathology and cardiovascular/T2DM risk. 
The research presented here has important potential implications. Externalizing problems 
are identified as a novel childhood risk factor for early development of CVD/T2DM risk, a 
finding that lends further support to hypotheses of the childhood origins of chronic diseases. 




problems and suggest that CVD/T2DM risk might need to be monitored in adolescents with a 
history of externalizing problems.  Although not formally tested here, these results also suggest 
that increased CVD/T2DM risk can develop in these children in the absence of excess adiposity. 
More research is needed to confirm these findings, to determine the extent to which these 









Figure 2. 1: Study di-acyclic graph, DAG 1 
 
 
Behavior	Problems, Ages	4	and	7y (Exposure) 
Study	covariates, Pregnancy	to	age	3.5	y (Confounders) 




Table 2.1: Distribution of study variables among study participants by BMI status at age 15, and by the study outcomes 
































Total, N (%) 7359 
(95.8) 
371 (4.8)  2899 (85) 523 (15)  3341 (97) 105 (3)  3068 (89) 378 (11)  
 N (%) P* N (%) P* N (%) P* N (%) P* 
Behavior Problems 
at ages 4 or 7 
 
            
Hyperactivity 
problems 
            
Never 6523 
(88.6) 




.010 2986 (89.4) 93 (88.8) .863 2763 
(90.1)) 
316 (83.6) .000 
Ever 836 (11.4) 57 (15.4)  292 
(10.1) 





            
Never 6036 
(82.0) 




.104 2783 (83.3) 86 (82) .721 2579 
(84.0) 
289 (76.7) .000 
Ever 1323 
(18.0) 




 558 (16.7) 19 (18)  489 (16.0) 88 (23.3)  
Emotional 
problems 
            
Never 6654 
(90.4) 




.471 3046 (91.2) 100 (95.0) .163 2790 
(90.9) 
355 (94.2) .036 




            
Sex       .182   .000   .850 
Male 3761 
(51.1) 




 1678 (50.2) 29 (27.8)  1519 
(49.5) 
189 (50.0)  
Female 3598 
(48.9) 




 1663 (49.8) 76 (72.2)  1549 
(50.5) 
189 (50.0)  
Race/ethnicity 
 
  .396   .574   .252   .045 
Table 2.1 Cont’d 
41 
	 
Non-white 274 (3.7) 17 (4.6)  112 (3.9) 18 (3.4)  125 (3.7) 6 (5.7)  124 (4.0) 8 (2.0)  
White 7085 
(96.3) 




 3216 (96.3) 99 (94.3)  2944 
(96.0) 
370 (98.0)  
Maternal education   .000   .000   .000   .003 
Less than high-
school  




 1695 (50.7) 35 (33.9)  1568 
(51.1) 
162 (43.0)  




 1646 (49.3) 70 (66.1)  1501 
(48.9) 
215 (57.0)  
Household income / 
week 
  .000   .07   .005   .180 
<200  1707 
(23.2) 




 630 (19.0) 28 (27.2)  581 (18.9) 78 (20.5)  
200-399 3755 
(51.0) 




 1741 (52.0) 55 (52.0)  1589 
(51.8) 
207 (54.8)  
400+ 1897 
(25.8) 




 970 (29.0) 22 (20.8)  898 (29.3) 93 (24.7)  
Family history of 
diabetes, Yes 
 
313 (4.3) 22 (5.9) .122 119 (4.1) 23 (4.3) .857 137 (4.1) 5 (4.8) .735 131 (4.3) 12 (3.1) .277 
Family history of 
hypertension, Yes 




.428 1113 (33.3) 42 (39.6) .177 1026 
(33.4) 
129 (34.1) .787 




Family history of 
heart disease, Yes 
 
922 (12.5) 48 (12.9) .817 366 
(12.6) 
71 (13.5) .578 426(12.7) 13 (12.7) .993 390 (12.7) 49 (13.0) .837 
Maternal history of 
diabetes 
 
  .030   .067   .323    
Never diabetes 6996 
(95.1) 




 3185 (95.3) 97 (92.4)  2919 
(95.2) 
362 (96.0) .355 
Ever diabetes 140 (1.9) 12 (3.2)  49 (1.7) 7 (1.4)  55 (1.7) 2 (2.1)  50 (1.6) 8 (2.0)  
Glycosuria in 
pregnancy 






73 (19.7) .010 440 
(15.2) 
96 (18.3) .065 524 (15.7) 16 (15.8) .982 489 (16.0) 51 (13.6) .249 
Gestational weight 
gain  
  .029   .008   .204   .237 
Below 
recommended 
966 (13.1) 51 (13.7)  365 
(12.6) 









 1027 (30.7) 34 (32.4)  958 (31.2) 102 (27.1)  











 1891 (56.6) 52 (49.7)  1722 
(56.1) 
222 (58.7)  
Preterm birth, Yes 376 (5.1) 13 (3.5) .168 143 (5.0) 31 (6.0) .343 168 (5.0) 7 (6.7) .443 156 (5.1) 19 (5.1) .990 
SGA, Yes 676 (9.2) 25 (6.7) .108 260 (19) 61 (12) .004 316 (9.5) 7 (6.7) .387 291 (9.5) 32 (8.5) .554 
LGA, Yes 807 (11.0) 64 (17.3) .000 337 (12) 69 (13) .287 402 (12.0) 9 (8.5) .271 375 (12.2) 36 (9.5) .123 
Breastfeeding   .001   .000   .000   .021 
Never 1632 
(22.2) 




 651 (19.5) 37 (35.8)  600 (19.5) 89 (23.5)  
< 3 months 1686 
(22.9) 




 763 (22.8) 10 (9.2)  673 (21.9) 99 (26.3)  
3-5 months 1248 
(17.0) 
65 (17.5)  502 
(17.2) 
93 (17.7)  581 (17.4) 18 (16.4)  545 (17.8) 54 (14.2)  
6+ months 2793 
(38.0) 




 1346 (40.3) 40 (38.6)  1250 
(40.8) 
136 (36.0)  
 BMI at age 15, 
at or above CDC-
95th Pctl, Yes 














 Mean (SD)  Mean (SD)  Mean (SD)  Mean (SD)  
Age, years 15.5 (0.3) 15.5 
(0.3) 
.235 17.2 (1.1) 16.7 (1.2) .000 17.1 (1.1) 17.2 (1.0) .137 17.1 (1.1) 17.2 (1.1) .060 
44 










5.7 (5.2) 5.9 (5.2) .737 5.7 (4.5) 6.0 (4.9) .232 5.8 (4.6) 4.7 (4.2) .014 5.8 (4.6) 5.4 (4.2) .095 
Maternal age at 
delivery 
 
29.5 (4.4) 28.9 
(4.3) 
.106 29.4 (4.4) 28.9 (4.5) .018 29.3 (4.4) 28.8 (3.8) .174 29.4 (4.4) 28.8 (4.5) .009 










39.4 (1.8) 39.6 
(1.4) 
.170 39.5 (1.8) 39.4 (1.9) .147 39.5 (1.8) 39.4 (1.8) .782 39.5 (1.8) 39.5 (1.7) .858 
All tables and tests adjusted by IPCW  
SGA: Small-for-gestational-age; LGA=Large-for-gestational-age 
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Table 2. 2: Relative risk of insulin resistance in late adolescence associated with behavior 




HOMA-IR      




Model 12 Model 23 Model 34 Model 45  






      0.274 
Never 
 
2607 450 1.00 1.00 1.00 1.00  
Ever 292 73 1.32 (1.05 
- 1.66) 
 














      0.981 
 
Never 2430 423 1.00 1.00 1.00 
 
1.00  
Ever 469 100 1.17 (0.96 
- 1.44) 
 














      0.349 
Never 
 
2651 473 1.00 1.00 1.00 1.00  













1 Behavior problems (hyperactivity, conduct, and emotional problems) were all modeled separately 
 
2 Model 1 is adjusted for: Age, sex, race/ethnicity 
 
3 Model 2 is adjusted as model 1 plus: Maternal education, Household income, maternal age at delivery, and maternal 
depression 
  
4 Model 3 is adjusted as model 2 plus maternal weight-gain during pregnancy, gestational hypertension, child’s birth weight, 
and breastfeeding 
 
5 Model 4 is adjusted as model 3 plus BMI at age 15 ³ CDC-95th percentile  
 
6 p-value for the behavior problem*sex interaction term added to model 3 
 




Table 2. 3: Relative risk of high LDL-Cholesterol levels in late adolescence associated 
with behavior problems in childhood, N=3,446 
Behavior problem1 LDL-Cholesterol      




Model 12 Model 23 Model 34 Model 45  
 
 N RR (95% CI) p6 
Hyperactivity 
problems 
      0.692 
Never 
 
2986  93 1.00 1.00 1.00 1.00  
Ever 355 12 1.30 (0.69 – 
2.44) 
1.24 (0.66 – 
2.33) 
1.22 (0.66 – 
2.25) 
1.12 (0.62 – 
2.04) 
 
Conduct problems       0.572 
Never 2783 86 1.00 1.00 1.00 
 
1.00  
Ever 558 19 1.16 (0.71 - 
1.90) 
1.16 (0.70 - 
1.94) 







      0.889 
Never 
 
3046 100 1.00 1.00 1.00 1.00  
Ever 295 5 0.54 (0.22 - 
1.35) 
0.56 (0.23 - 
1.39) 





1 Behavior problems (hyperactivity, conduct, and emotional problems) were all modeled separately 
 
2 Model 1 is adjusted for: age, sex, and race/ethnicity 
 
3 Model 2 is adjusted as model 1 plus: Maternal education, household income, maternal age at delivery, and family history of 
heart disease 
 
4 Model 3 is adjusted as model 2 plus: maternal weight gain during pregnancy, and breastfeeding 
 
5 Model 4 is adjusted as model 3 plus BMI at age 15 ³ CDC-95th percentile  
 
6 p-value for the behavior problem*Sex interaction term added to model 3 
 




Table 2. 4: Relative risk of high triglyceridemia in late adolescence associated with 




Triglycerides      




Model 12 Model 23 Model 34 Model 45  
 
 N RR (95% CI) p6 
Hyperactivity 
problems 
      0.509 
Never 
 
2764 315 1.00 1.00 1.00 1.00  
Ever 305 62 1.68 (1.30 - 
2.18) 
1.65 (1.27 - 
2.14) 
1.61 (1.24 - 
2.09) 
1.50 (1.16 - 
1.95) 
 
Conduct problems       0.254 
Never 2580 289 1.00 1.00 1.00 
 
1.00  




1.51 (1.20 - 
1.90) 





      0.571 
Never 
 
2791 355 1.00 1.00 1.00 1.00  
Ever 278 22 0.65 (0.43 -
0.99) 
0.65 (0.43 - 
0.99) 
0.66 (0.42 - 
0.99) 
0.67 (0.44 - 
1.02) 
 
1 Behavior problems (hyperactivity, conduct, and emotional problems) were all modeled separately 
 
2 Model 1 is adjusted for: Age, sex, and race/ethnicity 
 
3 Model 2 is adjusted as model 1 plus: maternal education, maternal age at delivery, and maternal depression  
 
4 Model 3 is adjusted as model 2 plus: child’s birth weight, and breastfeeding 
 
5 Model 4 is adjusted as model 3 plus BMI at age 15 ³ CDC-95th percentile  
 
6 p-value for the behavior problem*Sex interaction term added to model 3 
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 	 Eligible pregnant women in the Avon County area N= 20,248  
	 Women who were contacted by ALSPAC N=16,734 
	 Children born and alive at year 1 N=13,978 
Women who accepted to participate and provided any data 
N=14,541  	
Children  
Children for whom behavior problems data 












Figure A.2. 2: Timing of assessment of study variables 
 




















-LGA5, SGA6 -Maternal 
depression  





-Maternal age at 
delivery 




       
-Family history 
of CVD7 and 
T2DM8 
       
-Gestational 
diabetes 
       
-Gestational 
hypertension 
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Table A.2. 1: Comparison of the prevalence of behavior problems at baseline between 




Behavior problems Frequency p-value 
 Baseline sample Retained sample  
 n= 7330 n= 3446  
Age 4 years    
Externalizing problems    
Hyperactivity 13.7 12.7 0.18 
Conduct problems 12.3 11.5 0.23 
    
Internalizing problems    
Emotional problems  4.3 4.0 0.46 
Peer problems 10.2 10.0 0.75 
    
Age 7 years    
Externalizing problems    
Hyperactivity 10.7 9.4 0.03 
Conduct problems 10.3 8.7 0.01 
    
Internalizing problems 6.4 5.9 0.27 
Emotional problems  6.7 6.1 0.22 
Peer problems    
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Table A.2. 2: Comparison of the prevalence of study covariates between the original 
sample and the sample retained through follow-up 
 
Variables % Missing in 
baseline sample 
Frequency, mean, or median P-value 
  Baseline sample Retained sample  
  N= 7330 N= 3446  
Sex, Female 0 51.4 49.7 .084 
Ethnicity, Non-white 0.34 3.8 3.9 .830 
Household weekly Income 13.7    
< 100  6.9 4.9 <.001 
100-199  16.0 13.6  
200-299  29.0 27.9  
300-399  22.4 24.4  
>400  25.8 29.2  
Mom’s education, 5.7    
Above “O-level”  56.7 48.9 <.001 
Neighborhood stress score, median 6.0 3.0 3.0 .736 
Mom’s depression score, median 4.0 5.0 5.0 .161 
Mom’s anxiety score, median 4.9 3.0 3.0 .225 
Pre-pregnancy weight, mean 8.5 60.6 60.6 .842 
Pregnancy diabetes 0.4 3.5 3.5 .950 
Pregnancy hypertension 2.4 14.9 15.5 .397 
Family history of diabetes 2.0 4.3 4.3 .967 
Family history of heart disease 2.0 12.6 13.0 .526 
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Table A.2.3: Co-occurrence of behavior problems, by age at assessment 
 
 
Age 4 years 
 
Hyperactivity problems  Conduct problems  Emotional problems  
N= 602  N=953  N=331  























Age 7 years 
 
 
Hyperactivity problems  
N=487 
 
Conduct problems  
N=793 
 
Emotional problems  
N=495 
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Common childhood externalizing behaviors such as hyperactivity and conduct problems 
are risk factors for obesity throughout the life course. Whether these behavioral diagnoses increase 
cardiometabolic risk in early life independently of their effect on body adiposity is currently 
unknown. We investigated the prospective association of childhood (ages 4 and 7 years) 
hyperactivity and conduct problems with clinically high levels of triglycerides in adolescence in a 
large birth-cohort study, the Avon Longitudinal Study of Parents and Children (ALSPAC). Using 
causal mediation methods, we tested for indirect effects (NIE) mediated by diet, sleep, physical 
activity, smoking, alcohol use and body mass index, as well as direct or no mediated- effects 
(NDE). Results: In both fully adjusted logistic-regression models, hyperactivity problems (OR= 
1.74, 95% CI = 1.29-2.37) and conduct problems (OR= 1.60, 95% CI = 1.23-2.09) were associated 
with increased triglycerides. Mediation analysis showed that the association of hyperactivity (NDE 
OR= 1.48, 95% (CI=1.12 -1.89), NIE OR= 1.08, (95% CI=0.98-1.14) and conduct problems (NDE 
OR= 1.40, (95% CI=1.10 -1.72), NIE OR= 1.07, (95% CI=0.98-1.14)) with triglycerides were only 
partially mediated. Body mass index and lifestyle health behaviors jointly mediated 19.6 % and 
19.3% of the total effects of hyperactivity and conduct problems on triglycerides, respectively.  
Conclusions: Childhood hyperactivity and conduct problems are associated with high levels of 
triglycerides in adolescence. Hyperactivity and conduct problems appear to influence triglycerides 







Attention-deficit /hyperactivity disorder, ADHD, is the most common behavioral diagnosis 
among children in the US, with a prevalence estimated by the 2016 National Survey of Children’s 
Health (NSCH) of 8.9 % among children aged 3-17 years. Among children with ADHD, 51 % had 
additional behavioral or conduct problems1. Determining the ways and extent to which childhood 
ADHD and conduct problems influence health through the life course is important, in particular, 
given that other more extensively studied mental health problems, such as mood disorders and 
anxiety, are now considered important contributors to the development of cardiovascular diseases2-
5.  
Although less investigated than mood disorders and anxiety problems, there is evidence of 
associations between ADHD and conduct problems with increased body adiposity in young and 
mid-adulthood6-9, which is itself associated with higher risk of cardiovascular disease. There is 
also some evidence that these associations may extend to CVD risk factors other than adiposity, 
and CVD itself. 
In a prospective, population-based study, distress proneness at age 7 was a strong predictor 
of type-2 diabetes in mid-adulthood10. In another large cohort study11, hyperactivity at age 7 
predicted increased carotid intima-media thickness in adulthood among women, and in the same 
cohort, high self-control (a measure of low externalizing problems) predicted absence of coronary-
artery calcification12. In yet another prospective study13 with long follow-up, conduct disorder at 
age 13 was predictive of death from CVD before age 65. And, in a cross-sectional examination of 
young US adults (NHANES), having 3+ DSM-IV symptoms of hyperactivity/impulsivity 
(retrospectively reported) was associated with CDC-defined Stage II hypertension14.  
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Indeed, my own prior research in the same sample as the present study, has shown what 
might be the first evidence to-date in a prospective cohort of a positive association of childhood 
hyperactivity and conduct problems with adolescent levels of triglycerides, a biological marker 
causally related to heart disease. In that analysis, children with hyperactivity or conduct problems 
were almost twice as likely to have clinically significant high levels of triglycerides at age 17. The 
associations of hyperactivity and conduct problems with triglycerides persisted after adjusting 
these behavior problems for each other and after adjusting for the children’s depressive symptoms, 
and a wide-range of family socio-demographic characteristics, history of CVD risk, maternal pre- 
and pregnancy factors, pregnancy outcomes, maternal mental health, and breastfeeding. These 
findings of a prospective association of hyperactivity and conduct problems with triglycerides 
were further strengthened by the observation that triglyceride levels did not vary between children 
with- and without hyperactivity or conduct problems at study baseline. 
A question that remains unclear in this literature is what may mediate the relationship 
between externalizing problems and CVD risk. While some of the literature discusses the 
neuroendocrine system, with dysregulation of the HPA-axis, as a potential pathway15, the most 
prominent hypothesis posits that these effects are largely mediated by mechanisms involving 
health behaviors, specifically, behaviors associated with increased body adiposity --poor diet, poor 
sleeping habits, sedentary lifestyle-- and by stress-coping, and sensation-seeking behaviors such 
as cigarette smoking, and alcohol use. Externalizing psychopathology is associated with 
impulsiveness, low-inhibitory control, and low self-regulation. These symptoms have been shown 
to associate with a myriad of negative health-behaviors, including overeating, and binge eating16, 
consumption of unhealthy diets with high content of sugar, low ratios of unsaturated-to-saturated 
fats, low in fiber content, and high intake of sugar-sweetened beverages17. Adolescents with 
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hyperactivity/inattention and conduct problems were found to be less physically active than 
peers18. Sleep disruption and shortened sleep are very common among children with ADHD19,20 
and/or conduct problems21, and compared with peers, these children tend to start drinking alcohol 
and smoking earlier, and to consume more alcohol and smoke more than their peers22. All of these 
behaviors have, in turn, been shown to associate with increased CVD risk.  
Unveiling what these mechanisms might be is important for three reasons. First, it could 
strengthen the case that these relationships are indeed causal. Second, it could help us better 
understand the ways by which psychopathology is biologically embedded to increase CVD risk. 
Third, it could help inform the design of interventions to reduce cardiometabolic risk in children 
with externalizing problems. And fourth, determining the extent to which externalizing symptoms 
increase CVD risk independently of adiposity has important implications for prevention, as it 
would suggest that BMI might not be a sufficiently sensitive measure to screen for CVD risk in 
children with hyperactivity or conduct problems. 
In the present study, and extending my prior research, I examined the mechanisms that 
underlie the prospective association of childhood externalizing problems with high levels of 
triglycerides in adolescence. Using data from a large population-based study, I assessed whether 
childhood hyperactivity and conduct problems had direct effects on triglyceride levels at age 17. 
Direct effects were defined as the effects that did not work by pathways involving health behaviors 
or BMI, all assessed throughout the follow-up period. In addition, I also estimated the proportion 
of the total causal effects of hyperactivity and conduct disorder that was explained by those 
pathways, or indirect effects.  
I hypothesized that hyperactivity and conduct problems influence triglycerides mostly by 
indirect, or mediated pathways. I further hypothesized that childhood BMI and health behaviors 
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are more important mediators, that is, that together they contribute more to the overall mediated 







Setting and participants  
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a large, trans-
generational birth-cohort study established in South West of England (Avon County of the Bristol 
area). The study, which drew from the general population, recruited pregnant women with 
expected dates of delivery between April 1, 1990, and December 31, 1992. ALSPAC’s core sample 
is made up of the 13,978 children that remained alive by year 1. The study design has been 
previously described in detail23,24. Briefly, throughout follow-up, the study assessed children by 
means of questionnaires completed by the main caretaker, child-completed questionnaires, and 
clinical assessments of physical health, starting at age 7.   This analysis is based on the subsample 
of children for whom complete data on behavior problems (exposure of interest) was available 
from assessments at ages 4 and 7 years (n=7730). This study follows this subsample up until clinic 
assessments at age 17 years. Of the 7730 participants included at baseline, n=3446 (45%) 
participants attended this clinic and provided measures for the study outcome. The degree of study 
attrition observed is similar to that reported in most other large, population-based, cohort studies. 
Compared with retained ones, lost to follow-up participants were more likely to have been 
classified as having externalizing problems at baseline, came from households with lower income, 
and had mothers with lower educational attainment (Appendix tables A.2.1 and A.2.2).  
 
Censoring weights 
Inverse probability of censoring weights (IPCW) was used to account for possible biases 
due to study attrition over the 10-year follow-up (55%). Weights were estimated as follows: I 
created a binary variable to indicate censoring (0=Outcome information available, 1=No outcome 
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information available). I fitted logistic regression models to estimate the unconditional and 
conditional probabilities of remaining uncensored (C=0) using behavior problem variables, 
conduct and hyperactivity problems, and study covariates as predictors of censoring status. 
Stabilized Censoring Weights (SCW) were estimated as: = P (C=0) /P (C=0 | A, Cov), where “A” 
represents variables reflecting the status on conduct and hyperactivity problems at each assessment 
point, ages 4 and 7, and “Cov” represents study covariates. The mean SCW was in the 0.999 -
1.000 range and the range of weights was 0.61-1.51.  These weights were applied to all tests for 






Behavior problems in study participants were assessed using the parent version of the 
Strengths and Difficulties Questionnaire (S&D) completed by the mothers or main caregivers at 
participants’ age 4 and 7-year follow-up.  
The S&D is a widely used tool for the assessment of common behavioral psychopathology 
in children of school age in large, non-clinical samples. It is composed of 25 items covering 4 
problem behaviors (emotional, hyperactivity, conduct, and peer problems) and one positive 
behavior (pro-social behaviors). Parents rate their child with respect to each of the 25 behaviors 
over the prior 6 months.  Scoring produces a total score that is considered a valid measure of the 
child’s overall psychological wellness as well as 5 subscale scores: emotional problems, 
hyperactivity problems, conduct problems, peer problems and pro-social score. My analyses used 
the hyperactivity and conduct problems scores obtained at the 4 years and 7 years old assessments.  
S&D scores correlate well with interview measures, differentiate clinical from non-clinical 
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samples, and correlate with clinical diagnoses of behavioral psychopathology. The reliability of 
the S&D scale was found to be satisfactory in a study using a large, nationally representative 
sample of British children aged 5-15 years (N=10,438) with mean Cronbach’s alpha across 
subscales 0.73, and mean, across subscales 4-6 months test-retest reliability equal to 0.6225.  
Scoring of the S&D questionnaire: Items in the scale are rated 0=Not true, 1=Somewhat 
true, and 2=Certainly true, with five items reverse-coded. Each of the subscales is scored separately 
by adding up the 5 items within them (Scores range= 0-10). Cut-off points for each subscale 
defining the categories “Close to average” (bottom 80%), “Slightly raised” (10%), “High”, (5%) 
and “Very high” (5%) have been estimated based on a large, non-clinical sample of British school-
aged children. In this study, I created two binary variables: 1) Ever hyperactivity problems (Ever 
HP), and 2) Ever conduct problems (Ever CP), each reflecting whether the participant was ever 




Fasting blood samples were obtained from participants at the age 15 and age 17 clinics, 
with some participants attending just one of the clinics. In this analysis I used age 17 clinic 
measures when available (73 % of participants) and age 15 measures otherwise, and multivariate 
analyses adjusted for age at assessment of triglycerides. Participants were instructed to fast 
overnight if they attended the clinic in the morning or to fast for at least 6 hours (they missed 
lunch) if attending in the afternoon. Blood samples were processed soon after collection, plasma 
was separated and immediately frozen at −80oC, without freeze-thaw cycles, until assays were 
conducted three to nine months later. Triglycerides levels were determined using a modified 
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version of the standard Lipid Research Clinics Protocol that employs enzymatic reagents. For these 
analyses, triglyceride levels were classified as “High” (³ 130 mg/dl) versus “Not high” (< 130 
mg/dl), as recommended by the National Health of Blood and Lung Institute Expert Panel on 
Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 
201126, for children ages 10-19 years.  
 
Study covariates 
Information on all study covariates was obtained during the period between recruitment 
into the study, at pregnancy, and the study participant’s first assessment of behavior problems 
(study exposure) at age 4 years. Information was obtained via questionnaires, completed by the 
mother or main caretaker, or was extracted from antenatal medical records of mothers if consent 
was attained. Information obtained during pregnancy included: participant’s ethnicity 
(White/Caucasian or other), maternal highest educational attainment (Below O-level -equivalent 
to less than completed secondary education-, O-level, A-level  -some certification beyond 
secondary education), number of previous pregnancies, whether the mother’s biological parents 
had any of diabetes (Yes, No), hypertension  (Yes, No), and heart disease (Yes, No). Information 
collected between birth and participants’ age of 4 years included: breastfeeding (never, < 3 months, 
3-5 months, 6+ months); maternal depression (Edinburgh Post Natal Depression Scale, total score 
was used); household weekly income (less than £100,  £100-199, £200-299, £300-399 and £400+); 
and neighborhood stress index (range 0-22, estimated by 11 questions about housing and 
neighborhood conditions).  Information extracted from antenatal medical records included: 
maternal age at delivery, birth weight, gestational age at delivery, maternal history of diabetes 
(never, ever before pregnancy, only during pregnancy), gestational hypertension (Yes, No), and 
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weight gain through pregnancy (less than recommended, as recommended, or above 
recommended, according to Institute of Medicine). These covariates were chosen based on prior 
literature indicating that they were or were possibly associated with childhood behavior problems 
and with cardiometabolic risk. Additional demographic and stressor variables available in the 
study, such as father’s and mother’s social class, were initially included but were ultimately not 
used because they were highly correlated with other covariates and did not appear to account for 
any significant residual confounding once other variables were already adjusted for. 
 
Study mediators 
1. Health Behavior variables 
 
Sleep at age 10 years 
I estimated average daily number of sleep hours based on mother’s answers to a mailed 
questionnaire. Mothers answered to questions including “What time (to the nearest minute) does 
your child normally go to bed in the evening” and a similar question for usual wake-up time in the 
morning. Sleep hours on weekdays and weekends were queried separately.  Answers were used to 
compute weekday and weekend average number of sleep hours. A variable indicating mean hours 
of sleep per day was derived after assigning proper weights to week and weekend average sleep 
hours.  
 
Dietary variables at age 13 years  
Dietary intake was assessed at age 13 by the administration of 3-day food diaries27,28 mailed 
to participants prior to their clinic visits. Participants were asked to record, with assistance from 
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parents or caretakers if needed, all foods and beverages consumed over two week days and one 
weekend day. At the clinic, participants interviewed with nutritionists to verify completeness of 
diaries, clarify notions of portion sizes, and strengthen inconsistencies in the reporting27,28. 
Children who did not provide dietary diaries (fewer than 10%) completed twenty-four-hour 
recalls27. The software DIDO (Diet In, Data Out), developed by the MRC Human Nutrition 
Research Unit (Cambridge, UK)28, was used for coding and weighting of foods data. Mean daily 
nutrient intakes were estimated using the nutrient analysis software BRIGADE. 
Dietary variables used in this analysis include total energy intake (kilocalories per day) (E), percent 
of total energy from fat (% E from fat), percent of total energy from carbohydrates (CHO) (% E 
from CHO), and number of sugar-sweetened beverage (SSB) servings per day. As done in prior 
ALSPAC studies28,29 I defined SSB as full-sugar fruit squashes, cordials, and fizzy drinks (i.e. 
soda) with added sugar. Squashes and cordials were recorded as full-volume (syrup plus added 
water), or as concentrate (without water). It was assumed that 140 g of water were added to 40 g 
of concentrate for drinking. A one serving of SSB was defined as 180 grams of beverage (1 cup), 
that is, 180 g of full-volume beverage or 40 g of concentrate. 
 
Dietary reporting error 
Error in self-reporting of food intake is common in epidemiological studies and has been 
described before30. Inverse or null associations between reported energy intake and BMI are often 
observed30. Although completely accounting for the bias caused by this error is unfeasible, 
methods have been developed that allow for the accounting of some of that bias.  
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The method developed by Huang et al. 31was applied to determine which participants had 
provided dietary intakes that were plausible given their age, sex, height, weight, and measured 
level of physical activity. For each participant, an R-value was estimated as: 
R= Reported energy intake (rEI) / Estimated energy expenditure (EEE), where EEE=Total Energy 
Expenditure (TEE) + Constant for energy deposition growth, and TEE= BEE (Basal Energy 
Expenditure) x Physical activity level (PAL).  Age-, sex-, height, and weight-specific BEE values 
were estimated applying formulas published by the DRI32 using participant’s own data.  PAL levels 
were assigned based on DRI guidelines32, using the participant’s estimates of MVPA (Minutes of 
moderate-to-vigorous physical activity per day) from accelerometer data. 
Using formulas for error propagation, age- and sex- specific 1 SD cutoffs for the R value 
were estimated as: 1 SD= √"#$%&' /d + "#(%)' +	"#,-%%' , and "#$%&' , where "#$%&' 	is the sample 
specific coefficient of variation in reported energy intake, d is the number of days of dietary 
reporting, "#(%)'  is coefficient of variation in the estimation of energy requirements by DRI 
formulas, and "#,-%%'  is the coefficient of variation in the measurement of TEE by doubly-labeled 
water protocols, from elsewhere in the literature. I used sex-and age-specific values for "#$%&' , ./0	"#(%)'  previously estimated for this ALSPAC sample and reported by Noel et al33.  
Participants with R -values within cutoffs (42 % of the sample) were considered “plausible” 
dietary reporters. 
 
Physical Activity at age 13 years 
Physical activity was objectively measured by using MTI Actigraph AM 7164 2.2 
accelerometers34,35. Children were asked to wear the accelerometer for 7 days. Data was considered 
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valid if the accelerometer was worn for at least 3 days, 10 hours per day34. The measure used in 
this analysis was average counts per minute (CPM) of overall activity per day. 
 
Alcohol intake at age 13 years 
Alcohol intake was assessed as part of dietary assessment. Participants recorded any intake 
of alcohol and the amount of alcohol was averaged over the days of diet assessment to obtain a 
measure of mean alcohol intake (grams/day). A binary variable was created to classify children as 
“High alcohol drinkers” or “Not high alcohol drinkers” using the 5 grams of alcohol per day cut-
off point.  
 
Cigarette smoking at age 15 years 
Participants completed a questionnaire about cigarette smoking at the 15-year clinic. 
Participants reported whether they were currently smokers, and if so, the frequency of smoking. 
In this study I classified participants as being smokers (Yes, No) if they reported smoking a 
cigarette a-day for the past 30 days. 
 
2. Body Mass Index, at ages 8 and 15 years 
Height and weight were assessed at the 8 and 15-year clinics with participants wearing 
only light clothes and no shoes. Using Tanita scales weight was recorded to the nearest 0.1 kg. 
Height was assessed with Harpender stadiometer and recorded to the nearest 0.1 cm36. BMI was 
calculated as weight (kg)/ height (cm)2. I created a variable to reflect BMI at age 8, another variable 
to reflect BMI change from age 8 to age 15, and a third variable to reflect whether participants 
qualified or not as obese at age 15 based on the CDC-published 95th percentile point of BMI for 
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age (in months) and sex.  
 
 
Missing covariate information 
 
The proportion of missing covariate values was, as one would expect, lower for covariates 
assessed during pregnancy and infancy than for covariates during follow up, in late childhood and 
adolescence. The proportion of missing values in variables considered confounders was typically 
below 5% and was the greatest for family income at 13%. Among variables considered mediators, 
all assessed during follow-up, the proportion of missing values was in general below 12 % and 
was the greatest for one variable related to sleep at 16%. Missing covariate information was 
assumed to be at random and was imputed using IVEware software generating five complete 
databases. All study variables were used to inform imputation. Analyses were conducted 
separately in each of these five databases and the inferences resulting from those separate analyses 





I examined the characteristics of participants by looking at the distribution of study 
variables and assessing bivariate associations by means of statistical tests for the difference of 
means (t-test), medians (Mann-Whitney test) or frequencies (Chi-Square), as appropriate for each 
comparison. We used multiple logistic regression to assess the main associations --the relationship 
of hyperactivity and conduct problems with triglycerides. To be able to interpret odds ratios as 
estimates of relative risk, I invoked the rare disease assumption, even though the prevalence of the 
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study outcome (high triglyceride levels) was 11.6 %, just slightly above the arbitrary cut-off point 
of 10 % set for the definition of rare outcome. When I used other regression approaches that readily 
provide measures of relative risk for non-rare outcomes (i.e. Log-Binomial Regression), models 
systematically ran into convergence problems after only a few covariates had been added in. A 
comparison of odds ratios and risk ratios from small models for which both statistical approaches 
could be applied without running into convergence issues, showed that, odds ratios overestimated 
risks. This overestimation did not exceed a factor of 1.1, which was considered acceptable. 
Logistic regression models were first adjusted for age at which triglycerides were assessed (17 or 
15 years), sex, and race. Models were then further adjusted for additional demographics, maternal 
characteristics, family history of cardiometabolic disorders, pregnancy and gestation-level 




I conducted mediation analysis to investigate mechanistic pathways linking hyperactivity 
and conduct problems with triglycerides. Following the causal inference literature37,38 the 
counterfactual approach was used to assess the role of several health behaviors and BMI as 
potential mediators of the main effect. These mediators were identified in the literature as being 
both associated with pre-existing conduct and hyperactivity problems, as well as predictors of 
elevated triglyceride levels. Through mediation analysis I sought to estimate how much of the total 
effects of hyperactivity and conduct problems on triglycerides operated through these specific 
mediators (indirect effects) and how much operated not through the mediators (direct effects). 
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The counterfactual framework has advanced the traditional approach for mediation 
analysis, developed by Baron & Kenny, in at least two important ways: 1) It has explicitly 
articulated and clarified the non-confounding assumptions that are needed for estimates of direct 
and indirect effects to have causal interpretation. Importantly, some of these assumptions are not 
exclusive to the counterfactual approach. Though seldom acknowledged, they are also required for 
causal inference within the traditional approach. 2) Unlike the traditional approach, the 
counterfactual approach allows for total effect decomposition into direct and indirect effects that 
have causal interpretation even in the presence of interactions and non-linearities.   
The counterfactual approach provides estimates referred to as “natural effects” (direct and 
indirect effects). In the estimation of natural effects the mediator is set at the values that it naturally 
takes under the different levels of the exposure in the sample where the main effect has been 
identified, therefore natural effects better preserve the exposure-outcome relationship39 and have 
an easier, and more intuitive causal interpretation. The counterfactual framework is, for these 
reasons, a more appealing approach in ideological mediation analyses that aim primarily at 
assessing pathways, or determining the relative importance of pathways to the total effect. The 
traditional approach, on the other hand, produces effects referred to as “controlled effects”, and in 
its estimation, the mediator is assigned to a fixed level in the whole population. Controlled effects 
are therefore more useful in evaluating the effect of interventions on the mediator.  
When more than one mediator is of interest, as in this analysis, the usual approach of 
assessing one mediator at a time may not be appropriate.  If, for instance, one mediator affects 
another mediator, the pathways from exposure to outcome through these mediators would at least 
partially overlap, and that overlapping section of the pathways would be counted twice if the 
mediators were assessed one at a time. Consequently, the sum of their proportions mediated would 
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total more than 100%, even if both mediators acted in the same direction. When the temporal order 
of the mediators is known, it is possible to assess the mediators sequentially, that is, to 
progressively add mediators to the model from first to last. When we add an additional mediator 
to a model, we determine 1) the joint mediated effect, and 2) the additional contribution of the last 
added mediator to the effect of mediators already in the model.  
 
Strategy for the assessment of mediation with multiple mediators 
 
I assessed mediation applying a sequential approach whereby mediators were added to the 
outcome model (which already included the specific explanatory behavior problem variables and 
confounding variables) in the order the mediators were assessed (See Fig. 3.2). In the first step I 
added BMI at 8 years. The estimated NDE at this step indicated the effect of hyperactivity or 
conduct problems on triglycerides through all pathways except the pathway that operates through 
BMI at age 8, while the estimated NIE indicated the effect mediated by BMI at age 8. In the next 
step, I added to the model all health behaviors assessed at ages 10-13 years: % of energy from fat, 
% of energy from carbohydrates, unsaturated/ saturated fats ratio, SSB, sleep, physical activity, 
and alcohol intake. The NDE in this step indicated the effect of pathways not through BMI at age 
8 or health behaviors at ages 10-13 years, and the NIE indicated the effect through these mediators 
jointly. In the third step I added two variables, a variable indicating BMI change from ages 8 to 15 
years, and a variable indicating whether the participant was obese at age 15, and in the last step I 
added smoking at age 15, with the corresponding NDE and NIE at these steps being interpreted 
following the same logic as above.  
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I tested for exposure-mediator interactions, separately for each mediator. Exposure-
mediator interaction terms were included in the models if they caused a change in the estimated 
NDE and NIE of 10% or more. 
 
Applying the counterfactual approach to assessment of mediation 
 
Definition of Natural Effects 
Let A denote the subject’s exposure, let Y denote the subject’s outcome, let M denote the 
subject’s value of the mediator, and let C denote the values of a vector of confounding variables 
that may affect, A, M, and/or Y. The natural direct effect, NDE, for a binary outcome and on the 
odds ratio scale, expresses how much the odds ratio would change, on average, if the exposure 
were set, possibly contrary to fact, at a higher level versus the exposure set to a lower level, and 
for each individual the mediator were set at the level it would have taken, for that individual, if the 
exposure was in the lower level.   
 




Where YaMa* is the subject’s value for the outcome Y if the exposure A where set, possibly contrary 
to fact, to a higher value =a, and the mediator M were set to what it would have been if A had a 
lower value=a*. Ya*Ma* is the subject’s value for the outcome Y if the exposure A where set, 
possibly contrary to fact, to a lower value =a* and the mediator M were set to what it would have 
been if A had a lower value=a*. 
 
With a binary outcome, we can define direct and indirect effects on a risk ratio or odds ratio scale
(VanderWeele and Vansteelandt, 2010). On the odds ratio scale, the total effect conditional on C ¼ c is given
by ORTEa;a"jc ¼ PðYa¼1jcÞ=f1% PðYa¼1jcÞgPðYa"¼1jcÞ=f1% PðYa"¼1jcÞg . The controlled direct effect on the odds ratio scale conditional on C ¼ c is
given by ORCDEa;a"jcðmÞ ¼ PðYam¼1jcÞ=f1% PðYam¼1jcÞgPðYa"m¼1jcÞ=f1% PðYa"m¼1jcÞg . The natural direct effect on the odds ratio scale conditional on
C ¼ c is given by ORNDEa;a"jcða"Þ ¼
PðYaMa" ¼1jcÞ=f1% PðYaMa" ¼1jcÞg
PðYa"Ma" ¼1jcÞ=f1% PðYa"Ma" ¼1jcÞg
. The natural indirect effect on the odds ratio scale
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indirect effect on the risk ratio scale conditional on C ¼ c is given by RRNIEa;a"jcðaÞ ¼ PðYaMa¼1jcÞPðYaMa" ¼1jcÞ . The total
effect then decomposes into the product of the natural direct and indirect effects on the odds ratio or risk
ratio scale: ORTEa;a"jc ¼ ORNIEa;a"jcðaÞ & ORNDEa;a"jcða"Þ and RRTEa;a"jc ¼ RRNIEa;a"jcðaÞ & RRNDEa;a"jcða"Þ.
The identification of direct and indirect effects requires various no unmeasured confounding assump-
tions. We will use the notation A??BjC to denote that A is independent of B conditional on C. Controlled
direct effects are identified if control is made for a covariate set C that includes all confounders of not only
the exposure–outcome relationship but also the mediator–outcome relationship. In counterfactual notation,
we require that for all a and m,
Yam??AjC ½1(
Yam??MjfA;Cg: ½2(
Assumption [1] can be interpreted as: conditional on C, there is no unmeasured confounding for the exposure–
outcome relationship. Assumption [2] can be interpreted as there is no unmeasured confounding for the
mediator–outcome relationship conditional on (A,C). Natural direct and indirect effects will be identified if
four no unmeasured confounding assumptions hold. Natural direct and indirect effects will be identified if, in
addition to assumptions [1] and [2], the following two assumptions hold, that for all a, a" and m,
Ma??AjC ½3(
Yam??Ma" jC: ½4(
Assumption [3] can be interpreted as: conditional on C, there is no unmeasured confounding of the
exposure–mediator relationship. On a causal diagram interpreted as a set of non-parametric structural
equations (Pearl, 2009), if assumption [2] holds, then assumption [4] will hold if there is no effect L of
exposure A that itself affects both M and Y, i.e. no mediator–outcome confounder that is itself affected by
the exposure A. If, however, there is an effect of the exposure that confounds the mediator–outcome
relationship, then natural direct and indirect effects will not in general be identified irrespective of whether
data is available on that variable or not (Avin et al., 2005). Exceptions arise under strong assumptions about
no interaction at the individual level (Robins, 2003).
We will now present a simple regression-based approach for the estimation of direct and indirect
effects, which we will extend below to allow for multiple mediators. Suppose assumptions [1]–[4] hold,
that Y and M are continuous and that the following regression models for Y and M are correctly specified:
E½Y ja;m; c( ¼ θ0 þ θ1a þ θ2m þ θ3am þ θ 04c
E½Mja; c( ¼ β0 þ β1a þ β 02c:
Then it can be shown (VanderWeele and Vansteelandt, 2009) that the average controlled direct effect and
the average natural direct and indirect effects are given by
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The natural indirect effect, NIE, expresses how much the odds ratio would change on 
average if the exposure were fixed, possibly contrary to fact, at a higher level A=a, and for each 
individual the mediator M were changed from the level it would take if the exposure was in the 
lower level A=a* to the level it would take if the exposure was in the higher level A=a.  
 
In formal terms the NIE is defined as 
 
 
Where YaMa is the subject’s value for the outcome Y if the exposure A where set, possibly contrary 
to fact, to a higher value =a, and the mediator M were set to what it would be if A had a higher 
value=a. YaMa* is the subject’s value for the outcome Y if the exposure A where set, possibly 
contrary to fact, to a higher value =a, and the mediator M were set to what it would be if A had a 
lower value=a*. 
 
As clarified by the causal inference literature, these effects are identifiable under the 
following assumptions: 
1-No unmeasured confounding in the adjusted relationship Exposure-Outcome 
2- No unmeasured confounding in the adjusted relationship Mediator-Outcome 
3- No unmeasured confounding in the adjusted relationship Exposure-Mediator 
4- No confounding of the Mediator-Outcome relationship that is an effect of the exposure, 
irrespective of whether that variable is available 
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the exposure A. If, however, there is an effect of the exposure that confounds the mediator–outcome
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Following VanderWeele and Vansteelandt40, I used inverse probability weighting to 
estimate NDE and NIE.  Inverse probability weighting provides estimates of marginal effects, that 
is, effects that are averaged over covariates. The approach requires the estimation of three 
counterfactuals or potential outcomes: P	(Y4	54∗ = 1|c), P	(Y4∗	54∗ = 1|c), and P	(Y4	54 = 1|c) 
(see above the definition of NDE and NIE based on these counterfactuals) 
To estimate P	(Y4∗	54∗ = 1|c) I first fit a covariate adjusted model for the outcome (Y) using 
multiple logistic regression including A*M interaction terms when appropriate. I then obtained a 
weighted average of the estimated probabilities of outcome=1 among unexposed participants, 
giving each participant the weight w1= P (A=0) / P (A=0| Cov). Similarly, to estimate P	(Y4	54 =1|c), I obtained a weighted average of the estimated probabilities of outcome=1 among exposed 
participants where each subject was given the weight w2= P (A=1) / P (A=1| Cov). Conditional 
and unconditional probabilities of A=0 or A=1 were estimated using logistic regression. To 
estimate P	(Y4	54∗ = 1|c), I used the logistic regression coefficients obtained earlier from the full-
model for the outcome Y to estimate the P (Y=1) in the subsample comprised by the unexposed 
participants (A=0), to whom I switched their exposure status to exposed (A=1) while keeping the 
values for covariates and mediators they had as unexposed subjects. I then obtained the weighted 
average of the predicted values for P (Y=1) under those conditions, giving each subject the weight 
w3= 1/ (1- P (A=1|Cov). See corresponding SAS code in the Appendix section A.3.1. 
These three counterfactuals were estimated for each of the mediation models and for each 
model NDE and NIE were estimated as: 
NDE= P	(Y4	54∗ = 1|c) / P	(Y4∗	54∗ = 1|c) 
NIE= P	(Y4	54 = 1|c) / P	(Y4	54∗ = 1|c) 
I bootstrapped to obtain 95% confidence intervals for the estimates of natural effects. 
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In addition, for each mediation analysis, I estimated the “Proportion Mediated” as: ORNDE 
x (ORNIE – 1) / (ORNDE x ORNIE – 1).  
In secondary analysis I investigated whether our results were possibly being unduly 
influenced by the presence of dietary mis-reporters. I did this by reassessing mediation in a 
subsample comprised of the participants (N= 2,460) that I classified as plausible dietary reporters 
based on our application of the method by Huang et al. described above. In further analysis in this 
subsample, I evaluated whether total caloric intake was possibly a mediator, regardless of diet 
composition. To test this, I added the variable kilocalories per day and a variable for height at age 
13 years, as caloric requirements are known to vary by age, sex, and height.  
All tests conducted in these analyses that involved the study outcome (high triglycerides), 
including bivariate association tests, regression models, are adjusted by means of IPCW to account 
for the effects of participant attrition through study follow-up. In mediation analysis, as per our 
approach, data was weighted for the probability of exposure, and mediators. SAS code for 
mediation analysis can be found in Appendix A.4.2.  Mediation analyses were repeated with each 
one of 5 imputed datasets and results were essentially the same. Results obtained with imputed 






Characteristics of study participants and the relationship of study variables with triglyceride 
levels at end of study (Table 3.1) 
 
This study sample was 50% female/male and overwhelmingly white (95%). Only 5% of 
participants were obese; 11 percent of the participants had clinically high levels of triglycerides, 
the study outcome, at the end of follow-up, with no apparent differences between male and 
females; at baseline, 11% of the participants met the study definition of hyperactivity problems 
and 17 % met the definition of conduct problems. Adolescents with high levels of triglycerides 
were significantly more likely to have had hyperactivity (16 % vs 10 %, p< .05), or conduct 
problems (23% vs 16%, p< .05) at baseline. They were slightly more likely to be white (98% vs 
96%, p< .05), their mothers were younger at birth (28.8 years vs 29.4 years, p< .05), had higher 
educational attainment at study baseline (57% vs 49%, p< .05), and were heavier before pregnancy 
(62.5 kg vs 60.2 kg, p< .05). Participants with high levels of triglycerides were less likely to had 
been breastfed for more than 3 months (50% vs 59%), or to had been breastfed at all (76% vs 
80%), p<0.05. During follow-up, at age 13 years, they consumed diets with lower percent of 
energy (E) from fats (34.9 % E from fat vs 35.5% E from fat, p< .05), had a slightly higher 
unsaturated/saturated (unsat/sat) dietary fats ratio (38 % unsat/sat vs 37 % unsat/sat, p=0.08), and 
a higher intake of alcohol (0.35 g/day vs 0.26 g/day p=0.07). They had higher BMIs at age 8 (17.7 
BMI units vs 17.0 BMI units, p< .05), had a larger increase in BMI between ages 8 and 15 years 
(5.5 BMI units vs 4.2 BMI units p< .05), and were more likely to be obese at age 15 (17% vs 4%, 
p p< .05) than adolescents with triglycerides within normal levels. They were slightly less likely 
than peers to provide plausible dietary reports  (37 % vs 42%, p= 0.08). 
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Bivariate relationships of hyperactivity and conduct problems with mediator variables 
(Table 3.2) 
Participants with hyperactivity or conduct problems at baseline slept slightly less than their 
peers at age 10 (hyperactivity: 10.34 hours vs 10.44 hours, p< .05, conduct problems: 10.40 hours 
vs 10.43 hours, p=0.18). At age 13, they consumed significantly more sugar sweetened beverages 
per day (hyperactivity: 0.78 servings vs 0.47 servings, p< .05, conduct problems: 0.61 servings vs 
0.49 servings, p< .05), were more likely to consume alcohol, especially youth with conduct 
problems (hyperactivity:  19% vs 16%, p=0.15, conduct problems: 21% vs 16%, p< .05), and were 
more physically active than their peers, in particular those of them with hyperactivity 
(hyperactivity: 589 cpm vs 551 cpm, p< .05, conduct problems: 570 cpm vs 552 cpm, p< .05). 
Neither the children with hyperactivity (40.5% vs 41.8%, p= 0.64) or with conduct problems (41.2 
% vs 41.7%, p=0.84) were more likely than their peers to provide implausible dietary reports.  
Participants with conduct problems were more likely than peers to smoke at age 15 (38% vs 29%, 
p< .05). Youth with hyperactivity problems had BMI at age 8 similar to that of peers, but they 
experienced a larger increase in BMI through follow-up (4.6 BMI units vs 4.3 BMI units, p< .05), 
and were significantly more likely to be obese at age 15 (17% vs 10%, p< .05).  A similar trend 
was observed when comparing youth with conduct problems to their counterparts, except that 
participants with conduct problems were already slightly heavier at age 8 (17.3 BMI units vs 17.1 
BMI units, p< .05). I compared (not shown in tables) baseline levels of triglycerides (geometrical 
means) in children with hyperactivity, and children with conduct problems, with their respective 
counterparts in a subsample of participants who attended the age 7 years clinic, n= 2353, for whom 
fasting measures of triglycerides were available. I did not find differences in triglyceride levels 
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across these groups at baseline (hyperactivity, p= 0.95, conduct problems, p= 0.34).  
 
Mutivariate regression modeling of the relationship of hyperactivity and conduct problems 
with triglycerides (Table 3.3) 
In multivariable logistic regression analysis, hyperactivity and conduct problems were each 
associated with high triglycerides and the relationships remained after control for confounding. 
Compared with non-hyperactive participants, those who had hyperactivity at study baseline had 
almost twice the odds of developing high triglyceride levels by adolescence (OR= 1.81 (95% CI: 
1.34 – 2.44) in models that adjusted for sex, age, and race; and in a model that further adjusted for 
maternal education, maternal age at delivery, maternal depression score, the child’s birth weight, 
gestational age at birth, and breastfeeding (OR= 1.74 (95% CI: 1.29 – 2.37). The corresponding 
relative odds for youth with conduct problems were OR= 1.62 (95% CI: 1.25 – 2.10) for the 
minimally adjusted model and OR= 1.60 (95% CI: 1.23 – 2.09) for the fully adjusted model. 
 
Mediation of the relationship of hyperactivity and conduct problems with triglycerides 
(Table 3.4) 
In analyses that used inverse probability weighting to assess the role of BMI and health 
behaviors in mediating the effects of hyperactivity on triglycerides, the total average effect of 
hyperactivity (averaged over covariates) was estimated to be OR= 1.63 (95% CI: 1.24 – 1.99). 
Note that this effect estimate varies slightly with the one obtained from regression models 
(reported in the section above). This difference is due to the weighting of data used for assessment 
of mediation. By weighting of data we estimate the effect of the exposure on the outcome averaged 
over the actual values of covariates in the sample. In contrast, the effect we estimate from 
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regression models is the effect of exposure on the outcome when all covariates take their reference 
level. Mediators were then added to the model, in a sequential fashion (See Fig. 3.2), and at each 
step, the estimated indirect effect indicated the effect of hyperactivity that was mediated by the 
combination of mediators in the model. No evidence was found of indirect effects mediated by 
BMI at age 8, health behaviors at ages 10-13 years, and BMI changes over follow-up and obesity 
at age 15, as these mediators were sequentially added to the model. In the last step, smoking at age 
15 was added and with its additional contribution the total estimated indirect effect was OR=1.08 
(95% CI: 0.98 – 1.14), a very small effect that would account for only 19.6 % of the total effect of 
hyperactivity. The same strategy was applied for the assessment of mediation of the effect of 
conduct problem on triglycerides.  The total, average effect of conduct problems on triglycerides 
was OR= 1.50 (95% CI: 1.21 – 1.93). I found no evidence of any significant mediated effects as I 
sequentially added BMI at age 8, health behaviors 10 – 13 years, BMI change and obesity at age 
15 and smoking to the model. The total estimated effect mediated jointly by these mediators was 
only OR= 1.07 (95% CI: 0.98 – 1.14) explaining at most only about 19 % of the total average 
effect of conduct problems on triglycerides.  
The estimates of mediated effects were essentially the same in secondary analyses 
conducted in a subsample (42 % of the full sample) of plausible dietary reporters (not shown). In 
these analyses the role of caloric intake was additionally assessed but no evidence was found to 





This research investigated whether childhood hyperactivity and conduct problems had a 
direct effect on adolescent levels of triglycerides, a biomarker that is causally related to coronary 
heart disease41. I used causal-mediation methods to estimate indirect effects, defined in this study, 
as the effects that work through pathways involving health behaviors and BMI, and direct effects, 
defined as all other pathways not involving those mediators.  I also estimated the relative 
contribution of those pathways to the total effects of hyperactivity and conduct problems on 
triglycerides.  
The results suggest that hyperactivity and conduct problems influence triglycerides levels 
mainly by direct effects. I did not find evidence of any significant indirect effects explained by the 
mediators examined. At most, about 20% of the total effects might have been mediated jointly by 
BMI status, BMI changes, and by health behaviors including, diet, physical activity, alcohol intake, 
and smoking. Furthermore, the small indirect effects would seem to be mostly driven by BMI, 
with no contribution from health behaviors, aside from a small effect of smoking. Overall, the 
pathways appear to be similar for hyperactivity and conduct disorder, except that early BMI (at 
age 8) and smoking at age 15 might have played a more important role in mediating the overall 
effect of conduct problems than of the effects of hyperactivity.   
Based on the findings of prior studies suggesting associations of externalizing behaviors 
with body adiposity and unhealthy eating16,17,20, sedentary lifestyle18, and substance use22, and the 
extensive prior evidence of strong relationships of body adiposity42, and of aspects of diet43 and 
physical activity with triglycerides44, I had expected to find larger estimates of indirect effects.  I 
had hypothesized that sleep, diet, and physical activity would be important drivers of the total 
effects, while adolescence BMI would explain a smaller portion once childhood BMI and health 
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behaviors in childhood had been taken into account.  
In these analyses, BMI at ages 8, and 15, obesity at age 15, and BMI change were each 
associated with hyperactivity, conduct problems and with triglycerides in bivariate associations. 
However, in IPW models that accounted for a wide range of confounders and for bias from study 
attrition, BMI variables did not seem to play an important role in mediating the relationships of 
hyperactivity and conduct problems with triglycerides. Some prior studies have found BMI to be 
an important mediator of similar relationships with Framingham CVD risk score10, hypertension11 
and carotid artery calcification in adulthood45. Discrepancies between our findings and those 
studies might be explained by differences in timing at outcome assessment (adolescence vs 
adulthood), examination of different CVD-related outcomes, due to differences in prevalence of 
obesity and of unhealthy behaviors, and due to different methodological approaches of accounting 
for confounding and other sources of bias. For example, the prevalence of obesity in this cohort 
was very low compared with the current obesity prevalence among US adolescents (5 % vs 21%, 
NHANES 2015-17). However, some more recent studies that reported associations of other 
common mental health problems with type-2 diabetes and CVD in US-based cohorts of young 
adults and older adults have also failed to find a significant role of BMI and unhealthy behaviors 
in mediating those associations46-48. 
My findings of no mediation by health behaviors were not surprising given my 
observations of very weak associations of health behavior variables with triglycerides, and the 
almost across-the-board null associations of dietary variables (with the exception of SSB) with 
hyperactivity and conduct problems. These null associations could reflect true, null causal 
relationships, or could have resulted from error in the measurement of health behavior variables.  
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In the case of dietary assessment, it is likely that the results from the analysis conducted in 
the full sample were biased due to error in measurement of diet. This is indicated by the finding of 
an inverse association of self-reported energy with BMI, a finding that is counterintuitive for a 
non-clinical sample. However, these results didn’t change when I replicated the analysis in the 
subsample of “plausible” dietary reporters. Findings of associations between diet and markers of 
CVD risk including BMI, from other studies in the ALSPAC sample, have been inconsistent, with 
associations found to be unstable over time.   One such study found that adherence to the  
“Processed” and “Packed lunch” dietary patterns at age 7 was associated with BMI at age 17, 
however, adherence to those dietary patterns at ages 10 and 13 did not associate with BMI. 
Furthermore, there were no associations between any of the dietary patterns at ages 7, 10, or 13, 
with either of blood pressure, blood lipids, or glucose at age 1727,29.  Two other studies in ALSPAC 
investigated the prospective relationship of SSB with body adiposity. In one of them, SSB at ages 
5 or 7 was not associated with fatness at age 929, but in the other study49, change in SSB intake 
from 10- to 13-years was associated with increased BMI at age 13.  
Sleep did not contribute to mediation of the main effects in this study, which was internally 
consistent given that sleep was not associated with triglycerides, and although statistically 
significant, the difference in sleep hours between children with hyperactivity or conduct problems 
with their study peers were very small.  This lack of variation probably owes to the fact that in the 
ALSPAC cohort sleep hours are in general very high. For illustration, at age 10, in the years 2000-
02, these children slept significantly longer hours than did same-age US children in 199750. 
Participants in our sample who ranked at the bottom 10th percentile of sleep hours slept 
significantly more (9.6 hours vs. 8 hours) than did children at the 10th percentile of sleep hours in 
the US general pediatric population50.  Furthermore, hyperactive children in our study who ranked 
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below the 5th percentile of sleep hours among hyperactive children (that is, the hyperactive children 
who slept the least among hyperactive children) still slept more (8.3 hours versus 8 hours) than did 
US children of the general population who ranked higher, at the 10th percentile. ALSPAC children 
also slept longer hours compared with more recent UK cohorts. In a study that compared sleep 
hours at age 14 between ALSPAC participants who were 14 in 1995, and participants in the 
Millennium Cohort Study who were 14 in 2005, showed that the % of teens that slept fewer than 
8 hours/day grew from 5.7 in 1995 (ALSPAC) to 13.4 in 2005 (Millennium Cohort Study).  
Contrary to what I had expected, physical activity was, if anything, a negative mediator. I 
found that children with externalizing behaviors were more, not less, physically active than their 
peers. Physical activity had a small inverse relationship with triglycerides, therefore in this sample, 
physical activity was possibly a pathway through which hyperactivity and conduct problems might 
have reduced triglycerides. It’s been posited that children with low self-control would be less likely 
to engage in group-based structured physical activity that requires self-control and involves social 
interaction7. Based on this theory and the known negative effects of physical inactivity on blood 
lipids44, I had hypothesized that low physical activity would be a mediator (positive).  However, it 
is also entirely plausible that the elevated motor activity that children with externalizing problems 
sustain throughout the day more than compensates for the lack of time spent on group-based 
physical activity, to achieve the higher daily total counts of physical activity that I observed among 
these children, compared with their study peers. 
Clinical evidence shows that at any given point, triglyceride values are reflective of the 
person’s recent (past few months) diet, physical activity, and smoking43,44,51. Thus, for childhood 
health behaviors to be mediators of the association of childhood externalizing problems with 
triglycerides at age 17, differences in health behaviors between children with and without 
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externalizing problems should persist into age 17. It is plausible, however, that these differences 
in health behaviors become insignificant by adolescence as youth gain independence and greater 
control over their diet and lifestyle choices and poor choices become more normative. The erasing 
of the differences in unfavorable health behaviors among children with and without externalizing 
problems might explain our observation that health behaviors assessed before adolescence were 
associated with childhood hyperactivity and conduct problems but not with triglycerides at age 17.  
Alternatively, it is possible that the children that are at higher risk of developing high 
triglycerides are in fact the subset of children with childhood externalizing problems that persist 
into adolescence, or the predominantly hyperactive, or inattentive types52, which I did not 
discriminate among in this analysis. This subset of children might be more likely to adopt 
unfavorable and persisting health behaviors and to do so at higher levels, with a more significant 
clinical impact on triglyceride levels. 
Finally, these findings may lend support to the alternative main hypothesis that the 
relationships between externalizing problems with triglycerides might be mediated by 
neurochemical effects associated with dysregulation of the SNP and HPA-axis, the body’s system 
for response and adaptation to acute and chronic stress, observed among both adult and pediatric 
externalizing disorders53-56.  Stress-mediated persistent activation of the HPA axis leads over time 
to dysfunction and alteration of glucocorticoid pathways and metabolism with consequences for 
the immune and endocrine systems linked to increased cardiometabolic risk. Alterations of the 
immune system reflected by elevated levels of Interleukin-6 and fibrinogen have been documented 
in children exposed to chronic levels of stress57,58 and among children with externalizing behavior 
problems59. Chronic high levels of inflammation induce changes in lipids profiles, including the 
increase in blood concentrations of triglycerides60. Furthermore, It is posited that childhood 
		 96		
chronic stress could act as a modifying factor in the maturation process of the still plastic SNP and 
HPA axis thus becoming embedded in a lasting fashion, with life-long effects on the body’s 
vulnerability to chronic disease61,62.  
These results should be considered in the context of some study-specific limitations. First, 
I relied on parent’s reports, rather than clinical interviews, for the assessment of participant’s 
externalizing problems. However, the SDQ is a well-validated tool for use in large epidemiological 
studies and I considered it appropriately valid and precise for the goals and the context of the 
research. Second, I did not have baseline values of study outcome for the entire study sample and 
relied on a secondary analysis on a subsample of participants for whom those measures were 
available to infer that triglyceride levels did not vary between participants with and without 
externalizing problems at baseline. Third, as an observational study, this one is liable to bias due 
to unmeasured confounding. For example, I did not adjust for use of psycho-stimulant drugs, which 
are commonly used to treat children with hyperactivity and low self-control. However, these drugs 
have been shown to reduce levels of triglycerides63, therefore, if anything, these results are biased 
to the null and our effect estimates are conservative. I controlled for maternal biological family 
history of CVD and diabetes but I did not have information on paternal family history, therefore 
results my bear some confounding resulting from this omission.  Overall, however, my strategy 
for control of confounding was robust and the results are essentially valid. Fourth, like most life-
course studies, ALPSAC suffered from significant attrition (50%).  Unlike most studies however, 
I used inverse probability of censoring weighting in all my analyses, and this approach likely 
reduced some of the bias created by attrition. Lastly, and as discussed above, this sample was 
significantly healthier than contemporary US cohorts and more recent UK cohorts with regards to 
BMI and health behaviors hypothesized in this study to be mediators. These factors may contribute 
		 97		
more importantly to mediation of main effects in less healthy cohorts. For example, in U.S cohorts 
that include more disadvantaged segments of the population, including ethnical minorities, 
children of parents with less education, and less social and financial resources, poor health 
behaviors will likely be more prevalent and have a greater role in mediating the relationships 
studied in this research.  
This study had also numerous important advantages including the use of a large, 
population-based birth-cohort, known for the quality of its assessments and data. I relied on two 
separate assessments of the participant’s externalizing problems to be able to identify both, earlier 
and later onset cases. Unlike most similar and prior studies investigating mediation, this study had 
an ideal design, whereby mediator variables were assessed in the middle of the follow-up period, 
preserving temporal relationships and thus improving our ability for drawing causal inferences.  
My approach to confounding control was robust and more comprehensive than in most other 
studies, addressing a wide range of factors including family history of cardiovascular disorders, 
socio-economic status, maternal factors including body adiposity, history of mental health, 
education, pregnancy outcomes, birth and childhood outcomes strongly associated with 
cardiovascular health later in life, including breastfeeding. I applied state-of-the-art methods for 
assessment of mediation that allowed me to account for exposure-mediation interactions and the 
estimation of natural effects with a more readily causal interpretation. I was able to assess all the 
most important health behaviors thought to be implicated in the main effects, including objectively 
assessed measures of physical activity and body adiposity.  
In summary, this study shows solid evidence that a history of childhood externalizing 
problems is directly associated with a moderate increased risk of developing clinically high levels 
of triglycerides by adolescence, regardless of body adiposity and the known propensity among 
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children with externalizing symptoms to the adoption of unhealthy behaviors. These findings have 
critical implications for clinical and research practice. First, they suggest that health practitioners 
may need to start assessing triglyceride levels in adolescents with a history of childhood 
hyperactivity or conduct problems, even among adolescents with healthy weight, and especially 
among children not treated with psycho-stimulants (known to reduce triglycerides). These children 
might require dietary modifications –or other appropriate approaches- that specifically target 
triglycerides but not body weight.  Second, future research studies should seek to replicate these 
findings in more recent cohorts known to bear much higher prevalence of obesity and unhealthy 
health behaviors. Third, future studies should also seek to obtain repeated assessments of health 
behaviors throughout follow-up, especially given that health behavior norms change from 
childhood to adolescence.  Conducting repeated assessments of these behaviors would be 
necessary to disentangle temporal variations in health behaviors that are due to normative, age-
related changes and changes that are due to the influence of externalizing problems. Fourth, future 
studies should also examine whether the risk of high triglycerides varies among adolescents with 
childhood-limited, adolescence-onset, and childhood-onset persistent externalizing problems, and 
whether different phenotypic sub-types including inattentive, hyperactive, and more antisocial 
types, differ in their associations with health behaviors and CVD risk. Future studies should 
include measures that allow the characterization of these subtypes using stratified sampling 
approaches to ensure adequate power to study these relationships.  
These findings also clearly warrant more and expanded research on mechanisms linking 
childhood externalizing problems with triglycerides other than health behaviors and body 
adiposity. Over the past decade a growing literature has examined disruption of the SNP-HPA in 
children and adolescents with externalizing psychopathology. The research suggests that these 
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changes in SNP-HPA and downstream pathways might also vary over time64, which further adds 
to the formulation made above that, in order to significantly expand our understanding of these 
associations and the mechanisms that underlie them, next studies must rely on repeated 
assessments of mediator variables. If, as our study suggests, externalizing problems influence 
triglyceride levels mainly by neurochemical pathways, that is, regardless of body adiposity and 
health behaviors, additional new research would be needed to investigate what therapeutical 
approaches, including perhaps anti-inflammatory treatments, might be effective in reducing high 





Figure 3. 1: Study Di-acyclic Graph. The hypothesized main causal relationship of 
hyperactivity or conduct problems with triglycerides is depicted by red line. Mediator variables 
are shown in blue. Time at assessment of study variables is shown in parentheses. Mediating 










Figure 3. 2:  Mediation analysis using a sequential approach: At each step (model #), 







 * BMI8 = BMI at age 8 y, HB = Health Behaviors (Sleep at age 10y, diet, sugar-sweetened beverages, alcohol, and 
physical activity at age 13y), BMI15 = BMI at age 15y, SMK = Smoking at age 15 y.  
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Table 3. 1: Characteristics of study participants  
 
 
 N (%) BMI  Triglycerides  








 < 130 mg/dl ³ 130 mg/dl  
Total, N (%) 3446 
(100%) 
3273 (95) 173 (5)  3068 (89) 378 (11)  
Behavior Problems 
at ages 4 or 7 years 
 
 N (%) P* N (%) P* 
Hyperactivity 
problems 
   .008   < .001 
Never 3079 (89) 2934 (90) 144 (83)  2763 (90) 316 (84)  
Ever 367 (11) 339 (10) 29 (17)  305 (10) 62 (16)  
Conduct problems    .003   < .001 
Never 2869 (83) 2746 (84) 130 (75)  2579 (84) 289 (77)  
Ever 577 (17) 527 (16) 43 (25)  489 (16) 88 (23)  
 
 
       
Study covariates 
(Before age 4 y) 
 
 N (%) P* N (%) P* 
Sex,     .630   .850 
Male 1707 (50) 1622 (50) 89 (51)  1519 (50) 189 (50)  
Female 1739 (50) 1651 (51) 84 (49)  1549 (50) 189 (50)  
Race/ethnicity 
 
   .592   .045 
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Non-white 131 (4) 125 (4) 8 (5)  124 (4) 8 (2)  
White 3315 (96) 3148 (96) 165 (95)  2944 (9) 370 (98)  
Maternal education    < .001   .003 
Below ‘O’ level 1730 (50) 1669 (51) 61 (35)  1568 (51) 162 (43)  
At or above ‘O’ 
level 
1716 (50) 1601 (49) 112 (65)  1501 (49) 215 (57)  
Household income / 
week 
   < .001   .180 
<200  658 (19) 610 (19) 49 (28)  581 (19) 78 (21)  
200-399 1796 (52) 1700 (52) 94 (55)  1589 (52) 207 (55)  
400+ 992 (29) 963 (29) 30 (17)  898 (29) 93 (25)  
Family history of 
diabetes, Yes 
 
142 (4) 139 (4) 8 (5) .811 131 (4) 12 (3) .277 
Family history of 
hypertension, Yes 
 
1155 (34) 1126 (34) 59 (34) .936 1026 (33) 129 (34) .787 
Family history of 
heart disease, Yes 
 
439 (13) 425 (13) 21 (12) .747 390 (13) 49 (13) .837 
Maternal diabetes    .062   0.370 
Never diagnosed 
with diabetes 
 3134 (96) 163 (94)  2931 (96) 364 (97)  
Ever diagnosed 
with diabetes 
 139 (4) 10 (6)  137 (4) 14 (3)  
        
Gestational weight 
gain  
   .050   .237 
Below- 442 (13) 412 (13) 21 (12)  388 (13) 53 (14)  
Table 3.1 Cont’d  
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540 (16) 500 (15) 37 (21) .031 489 (16) 51 (14) .249 
Breastfeeding    .004   .021 
Never 688 (20) 526 (16) 37 (21)  600 (20) 89 (24)  
< 3 months 773 (22) 657 (20) 48 (28)  673 (22) 99 (26)  
3-5 months 599 (17) 583 (18) 30 (17)  545 (18) 54 (14)  








427 (12) 396 (12) 31 (18) 0.024 375 (12) 36 (10) 0.123 
Preterm birth, Yes 179 (5) 173 (5) 6 (4) 0.294 157 (5) 19 (5) 0.990 
  Mean (SD) or Median (IQR) P* Mean (SD) or Median 
(IQR) 
P* 
Age, years, mean - 15.5 (.3) 15.5 (.3) .215 17.1 (1.1) 17.2 (1.1) .060 
Neighborhood stress 
index, mean 
3.7 (3.2) 3.7 (3.2) 4.4 (4.1) .070 3.7 (3.2) 3.8 (3.6) .806 
Maternal age at 
delivery, mean 






59.7 (11.1) 71.8 (18.3) < .001 60.2 (11.7) 62.5 (14.0) .002 




score, median (IQR) 









39.5 (1.8) 39.4 (1.8) 39.6 (1.4) .181 39.5 (1.8) 39.5 (1.7) .858 
Mediator variables   N (%) P* N (%) P* 
Cigarette smoking, 
Yes 
1049 (30) 984 (30) 57 (33) .354 923 (30) 127 (34) .161 
Alcohol, Yes 572 (17) 530 (16) 32 (18) .424 498 (16) 74 (20) .104 
Dietary reporting    < .001   .136 
Under-reporter 1249 (36) 1136 (35) 109 (63)  1095 (36) 155 (41)  
Plausible reporter 1456 (42) 1402 (43) 51 (29)  1308 (42) 147 (39)  
Over-reporter 740 (21) 735 (23) 13 (8)  665 (22) 75 (20)  







0.51 (1.55) 0.37 (1.39) .097 0.51 (1.54) 0.51 (1.65) .421 
% Calories from fat, 
mean 
35.5 (5.8) 35.5 (5.8) 35.4 (6.4) .927 35.6 (5.8) 34.9 (6.0) .037 
% Calories from 
carbohydrates, mean 
53.4 (6.4) 53.5 (6.4) 52.6 (7.5) .083 53.4 (6.4) 53.8 (6.8) .214 
Unsat. fats/ Sat. fats 
ratio %, mean 
34.4 (6.5) 38 (6) 36 (6) .012 37 (6) 38 (6) .080 
Kcal/day, mean 1960 
(506) 
1971 (504) 1839 (546) .083 1964 (504) 1928 (521) .192 






0.27 (.81) .31 (91) .662 0.26 (.81) 0.35 (.96) .068 
Sleep, average 
hours/ day, mean 
10.4 
(0.62) 
10.4 (.6) 10.4 (.7) .780 10.4 (.6) 10.4 (.6) .548 




556 (184) 530 (168) .071 557 (184) 541 (175) .117 
BMI, age 8 y 17.1 (2.3) 16.9 (2.1) 21.3 (2.9) < .001 17.0 (2.3) 17.7 (2.8) < .001 
Change in BMI, 
ages 8y to 15y, 
mean 
4.3 (2.4) 4.0 (2.1) 9.5 (3.2) < .001 4.2 (2.3) 5.5 (3.2) < .001 
BMI at age 15, at or 










Inverse probability of censoring weights (IPCW) were applied to all tables and tests 
Table 3.1 Cont’d 
	 
Table 3.2: Relationship of Hyperactivity and Conduct Problems with Health Behavior variables, bivariate associations  
 




 Average # sleep hours 
per day1,4,  
# SSB servings per day2,4 Uses alcohol, Yes3,4 PA, Average CPM1,4 Smoking, Yes3,4 
Age at 
assessment 
 10 y 13 y 13 y 13 y 15 y 
 N (%) Mean (SD) p Median (IQR) p N (%) p Mean (SD) p N (%) p 
Hyperactivity 
Problems 
           
No 3078 (89) 10.44 (.62) .005 0.47 (1.49) < .001 501 (16) .152 551 (183) < .001 934 (30) .608 
Yes 360 (11) 10.34 (.63)  0.78 (1.83)  71 (19)  589 (177)  116 (32)  
Conduct 
Problems 
           
No 2869 (83) 10.43 (.61) .182 0.49 (1.48) < .001 450 (16) .002 552 (183) .038 830 (29) < .001 
Yes 577 (17) 10.40 (.67)  0.61 (1.71)  121 (21)  570 (182)  219 (38)  
1 Differences of means were assessed by T-tests.  
 
2 Differences of medians were assessed by Wilcoxon tests 
 
3 Differences of proportions were assessed by Chi-Square tests. 
 




Table 3.3: Relationship of Hyperactivity and Conduct Problems with Triglycerides. 









Model 11,3 Model 22,3 








    
Never 
 
2764 315 1.00 (Ref) 1.00 (Ref) 
Ever 305 62 1.81 (1.34-2.44) 
 
1.74 (1.29 - 2.37) 
 




    
Never 2580 289 1.00 1.00 
 
Ever 489 88 1.62 (1.25 – 2.10) 
 
1.60 (1.23 – 2.09) 
 
Hyperactivity Problems and Conduct Problems were modeled separately. 
 
1 Model 1 is adjusted for age, sex, and race/ethnicity. 
 
2 Model 2 is adjusted as model 1 plus maternal education, maternal age at delivery, maternal depression, child’s 
birthweight, gestational age, and breastfeeding. 
 
3 Inverse probability of censoring weights (IPCW) were applied to all models. 
 
	 
Table 3.4: Mediation of the relationships of Hyperactivity and Conduct Problems with Triglycerides by health behaviors and 
BMI.  Odds Ratios (95% CI) for the marginal (averaged over covariates) Natural Direct (NDE), Natural Indirect (NIE), and 
Total Effects (TE)  
 
 
 Hyperactivity Problems  Conduct Problems  
Mediators in Model NDE NIE TE PM (%) NDE NIE TE PM (%) 
 OR (95% CI)  OR (95% CI)  
         
None - - 1.63 
(1.24 – 1.99) 
- - - 1.50 
(1.21 – 1.93) 
- 
         
M1=BMI 8y 1.61 
(1.24 – 2.01) 
1.00 
(0.96 – 1.03) 
1.61 
(1.23 – 1.97) 
0.6 1.46 
(1.17 – 1.84) 
1.02 
(0.99 – 1.06) 
1.50 
(1.21 – 1.93) 
7 
         
M1 + M2= Health 
Behaviors 10-13 y 
1.61 
(1.26 – 2.03) 
1.01 
(0.93 – 1.04) 
1.61 
(1.23 – 1.95) 
1.4 1.46 
(1.17 – 1.83) 
1.02 
(0.97 – 1.05) 
1.49 
(1.20 – 1.92) 
6.3 
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M1 + M2 + M3= 
Obesity 15y and 
BMI change  
1.49 
(1.13 – 1.89) 
1.07 
(0.96 – 1.13) 
1.60 
(1.23 – 1.93) 
18.3 1.41 
(1.11 – 1.75) 
1.06 
(0.97 – 1.12) 
1.49 
(1.21 – 1.90) 
16.7 
         




(1.12 – 1.89) 
1.08 
(0.98 – 1.14) 
1.60 
(1.23 – 1.93) 
19.6 1.40 
(1.10 – 1.72) 
1.07 
(0.98 – 1.14) 
1.49 
(1.20 – 1.88) 
19.3 
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Figure A.3. 1: Causal mediation analysis -SAS code 
 
 	
*Hp,Counterfactual 1= P (YaMa*=1|cov); *Estimated conditional probabilities 
of each exposure statuses.  
Creates a dataset with a variable for those probabilities; 
 




class  sex kc404; 
 
model everhp= sex race agechol momed  depression  bwt bestgest momagedel 
kc404 ; 
 




data preda;*In the dataset PREDA, it gives the name pa1 to the variable 
prbability exposure=1; 
set preda; 
pa1=P_1;*Conditional probability of being E+=Propoensity score; 
run; 
 
data mydata0; *Creates a dataset that is copy of the original but the 






data mydata1; *Creates a dataset that is copy of the original but the 





*bmich bmi15 ssb13_new smokes avgsleephr13 pctfat fg13kcal fatratio fg3100 
age13mos; 
*avgsleephr everHP*avgsleephr pctfat pctcho  fatratio alcocat everhp*alcocat 
smokes cpm13  
ssb13_new fg13kcal fg3100  bmich cdcbmi95; 
 
proc logistic data=mydata ;*Full model for the outcome. Gives coeficient 
parameters that can be applied to estimate p of outcome in other datasets 
where 




class  sex  smokes alcocat cdcbmi95 kc404 ; 
model h_tri= everHP   bmi8 avgsleephr  pctfat pctcho  fatratio alcocat   
cpm13  
ssb13_new bmich cdcbmi95 smokes  sex race  agechol momed  depression  bwt 
bestgest momagedel kc404; *obtains model effect estimate; 
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weight SCW; 
score data=mydata0 out=predy0; * Estimates the probability of outcome=1 for 
each suject where everybody was set to E-, and the mediators too the original 
values; 
score data=mydata1 out=predy1; * Estimates the probability of outcome=1 for 





data predy0; *Renames probability of outcome =1 among all arbitrarily set to 





data predy1; *Renames probability of outcome =1 among all arbitrarily set to 
















proc reg data=mydataw; 
where everHP=0;*It averages this among only the unexposed  so they have the 
mediator as they have it when they are unexposed, but averages the outcome 
they would had, 
had they instead been exposed; 




*Counterfactual 2= P (Ya*Ma*=1/cov) (2); 
 
proc logistic data=mydata ; 
model everhp= ; 






Pa0=P_0; *P_0 stays there=unconditional probability of being unexposed; 
run; 
 





class  sex kc404 ; 
model everhp= race  sex agechol momed  depression  bwt bestgest momagedel 
kc404; 






Pa0cov=P_0;* Conditional probability of being unexposed; 
run; 
 
*ssb13_new avgsleephr smokes bmich cdcbmi95; 
*avgsleephr everHP*avgsleephr pctfat pctcho plausiblerep fatratio alcocat 
everhp*alcocat smokes cpm13  
ssb13_new fg13kcal fg3100 bmich cdcbmi95; 
 




class  sex  smokes alcocat kc404 cdcbmi95 ; 
 
model h_tri= everHP   bmi8  bmi8 avgsleephr  pctfat pctcho  fatratio alcocat   
cpm13  
ssb13_new bmich cdcbmi95 smokes sex race  agechol momed  depression  bwt 
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bestgest momagedel kc404; 
weight SCW; 





















proc reg data=mydataw1; 
where everHP=0; 
model py=; *Probability of outcome=1 among the unexposed with the mediators 






*Counterfactual 3=  P YaMa=1|cov) (3); 
 
proc logistic data=mydata; 
model everhp= ; 






Pa1=P_1; *P_1 stays there. Unconditional Probability of being exposed; 
run; 
 




class  sex kc404 ; 
 
model everhp= sex race  agechol momed  depression  bwt bestgest momagedel 
kc404; 
































Cardiovascular and Type 2 Diabetes Risk in Children with Externalizing Behavior 






















Externalizing disorders are the most common mental health diagnoses in children and 
adolescents, but despite their well-known association with obesity, it is unclear whether 
externalizing disorders and symptomatology are also risk factors for cardiovascular diseases 
(CVD) and type 2 diabetes mellitus (T2DM). Other common mental health problems, including 
depression and anxiety, are now established risk factors for these diseases. A systematic review 
was conducted following PRISMA guidelines (Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses) to summarize and assess consistency in the literature of the association of 
childhood and adolescence externalizing problems/disorders with increased CVD/T2DM risk. I 
assessed the literature for evidence on the developmental timing at which increased risk becomes 
evident (childhood, adolescence, young-, mid- adulthood, later in life), and for evidence that the 
relationship is independent of body adiposity. Studies were graded for quality of evidence.  
Results: Findings supported a positive association of externalizing problems with T2DM and 
insulin resistance (100 % of 5 assessments), and with increased blood lipids (100 % of 4 
assessments) among children and adolescents. Evidence was mixed and provided less support to 
the association with T2DM and blood lipids in adults (13% of 8 assessments) and among studies 
that assessed other outcomes in children or adults (69 % of 22 assessments). Studies in children 
were mostly cross-sectional and relied mainly on clinical assessments or on well-validated 
measures.  Studies in adults were mostly prospective and used less valid assessment methods. 
Associations persisted in all 9 assessments in which models adjusted for BMI. Conclusions: 
Children with externalizing problems have increased CVD/T2DM risk that is already apparent 
before adolescence. These children may have increased CVD/T2DM risk regardless of body 
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adiposity. More studies are needed to examine effects after adolescence. Future studies must 
employ prospective designs, well-validated measures of externalizing behaviors, and only rely on 
objective assessments of T2DM and CVD. New research is warranted to identify the mechanisms 








Cardiovascular diseases (CVD) and Type 2 Diabetes Mellitus (T2DM) are major causes of 
morbidity and mortality, worldwide and in the US1,2. These disorders and their biological 
precursors, once concentrated among older populations, are now increasingly diagnosed among 
the young3-5. Currently, only a fraction of CVD/T2DM can be explained by known risk factors and 
the identification of new ones, especially early-life risk factors, is a top priority in public health 
research3,6,7.  
Among adults, common internalizing mental health problems have recently been singled 
out as important contributors to the development and worsening of CVD/T2DM: depression, 
anxiety, and post-traumatic stress disorder (PTSD) are now, in fact, established risk factors for 
these diseases8-13. The role of externalizing psychopathology, on the other hand, has been 
investigated to a much lesser extent, which is surprising given the large body of research that 
supports associations, already evident in childhood, between Attention-deficit Hyperactivity 
Disorder (ADHD) and Conduct Disorder with obesity, itself a strong precursor of CVD/T2DM 14-
17. ADHD is the most commonly diagnosed behavioral disorder in the pediatric population, with 
approximately 10 percent of US children aged 3-17 years receiving a diagnosis, and as many as 
half of them displaying also additional behavioral or conduct problems18.  
That obesity risk is already increased in children15 and adolescents with ADHD or Conduct 
Disorder makes externalizing psychopathology not only a plausible early life risk factor for 
CVD/T2DM, but also a relevant one for public health given the high prevalence of externalizing 
problems. The processes that lead to the development of cardiovascular disorders require many 
years to develop. Extensive evidence shows that early detection and intervention to stop these 
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processes can have an impact in reducing morbidity and mortality. Identifying the developmental 
timing of the emergence of CVD and diabetes risk in children with externalizing problems could 
therefore be critical for timely intervention. 
Externalizing problems may be associated with CVD/T2DM through at least two pathways 
not involving increased body adiposity. First, persistent high levels of stress in psychopathology 
may disrupt the body’s stress-response systems, the SNS-HPA (sympathetic nervous system and 
the hypothalamus-pituitary axis). Consequences to this disruption include a cascade of 
neurochemical and neuroendocrine modifications that over time could lead to chronic high levels 
of inflammation and high levels of insulin. Chronic high levels of inflammation induce increases 
in blood lipids19. Persistent high insulin would, in turn, also lead to development of insulin 
resistance, and high levels of insulin and glucocorticoids are known to be key contributors to 
atherogenic processes in coronary arteries20. Second, externalizing psychopathology might 
influence CVD/T2DM through impulsiveness, low-inhibitory control, and low self-regulation. 
These symptoms have all been shown to associate with a myriad of unhealthy behaviors known to 
increase CVD/T2DM risk, at least in part, independently of body weight, including high-sugar 
content diets, high intake of sugar-sweetened beverages21, sleep disruption 22,23 24, physical 
inactivity, higher consumption  of alcohol, and earlier initiation of tobacco smoking 25.  
Identifying whether the association is substantively independent of body adiposity, through 
the pathways described above, would expand our understanding of the ways externalizing 
problems (and maybe mental health problems in general) get “under the skin” to cause physical 
disease. And in more practical terms, the finding could also provide new roadmaps for the 
formulation of interventions that ameliorate long-term consequences on physical health. By 
current clinical guidelines CVD/T2DM risk factors are assessed only among children/adolescents 
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with diagnosed overweight/obesity. If the relationship is only partially mediated by body adiposity 
then a sizable proportion of children with externalizing problems –those with body mass index 
within normal ranges- might be children with elevated, but unidentified and unaddressed, 
CVD/T2DM risk. 
To my knowledge no prior attempts have been made at summarizing the extant literature 
on the topic. This systematic review summarizes and assesses the evidence from existing research 
for consistency with regards to three particular questions of interest:  
1) Is there a positive association between externalizing behaviors/psychopathology, experienced 
during childhood and/or adolescence, and CVD/T2DM risk?  
2) When, during the life course (childhood, adolescence, young adulthood, later in life) does 
increased risk become evident?  
3) What is the evidence and the degree to which the relationship is independent of body adiposity? 
Data was extracted from peer-reviewed articles with regards to study setting, study design, 
sample size, methods used for assessment of externalizing behaviors/disorders and CVD/T2DM, 
study findings, confounding control, and study advantages and limitations. In addition, a 0-5 point 
quality grade system was developed and applied to individually assess each of the studies included 




This systematic review was conducted in accordance to Preferred Reporting Items for 




In order to be included in this systematic review, studies were required to be original 
research reports of the association between an externalizing behavior problem/disorder, first 
experienced during childhood or adolescence, and an outcome indicating the presence of 
cardiovascular disease, T2DM, or indicating an elevated risk for those diseases. This relationship 
needed to be explicitly tested and reported by the study. Specifically, the study outcomes had to 
be one of: ischemic heart disease, coronary heart disease, stroke, hypertension, blood pressure, 
atherosclerosis, carotid-artery intima media thickness, total cholesterol, low-density lipoprotein 
(LDL)-cholesterol, triglycerides, T2DM, insulin resistance, hyperglycemia, hyperinsulinemia, or 





Studies that met any of the following criteria were excluded from this review: 
 
• Study based on a selected sample, i.e. excluded subjects with ADHD, excluded subjects 
with obesity and chronic diseases, sample was made entirely of subjects with bipolar 
disorder, etc.;  
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• Study relied on global measures of psycho-behavioral problems that do not discriminate 
externalizing from internalizing behavior problems;  
• The unexposed group is made up exclusively of participants with other psychiatric 
diagnoses; 
• Studies in which outcome was inflammation. Although inflammation is a mayor 
component of the development of CVD/T2DM, inflammation is not considered a specific 
marker of CVD/T2DM as it is present in a wide range of disorders unrelated to the 
cardiovascular and energy metabolism systems; 
• The study outcome is a composite of chronic diseases that includes diseases unrelated to 
the cardiovascular or energy-metabolism systems or includes biomarkers known not to be 
causally associated with CVD or T2DM risk; 
• Report does not present results adjusted for sex and age;   
• Prospective studies that test whether CVD precursor or biomarker precedes the 
development of externalizing problems. 
 
Search Strategy 
Searches were conducted in two electronic databases, Pubmed/MEDLINE (Jan 9, 2019) 
and Web of Science (Feb 5, 2019). The search in Pubmed was built stepwise as follows: first, a 
list of search terms including medical subject headings and keywords associated with the concept 
of “externalizing behavior problems in children” was developed, that included: attention deficit 
and disruptive behavior disorder, child attention problems, child inattention, hyperactivity 
problems, attention deficit and hyperactivity problems, conduct disorder, child conduct problems, 
externalizing behavior problems, externalizing disorders, child behavior problems. These search 
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terms were grouped into a comprehensive “Exposure” search term using the Boolean operator 
(OR). Likewise, a list of medical subject headings designating cardiovascular diseases, T2DM, 
and their most common subclinical biological manifestations, was developed that included: 
cardiovascular diseases, hypertension, blood pressure, insulin resistance, hyperglycemia, 
hyperinsulinemia, type 2 diabetes mellitus, atherosclerosis, cholesterol, triglycerides. These search 
terms were also grouped using (OR) to create a comprehensive “Outcome” search term. The 
“Exposure” and “Outcome” search terms were then combined by (AND) to create the final term 
that was used to search for articles in Pubmed/MEDLINE. The search on Web of Science was 
conducted using the same search terms and the Topics option.  Search results were limited to full-
text articles, English language, and publication years between 1980 and 2018. Search terms are 
listed in Appendix Figure. A.4.1. 
The searches on Pubmed/Medline and Web of Science retrieved n=1,383 and n=2,972 
titles, respectively (Figure 4.1). Manual reviewing of these titles led to the selection of 91 articles, 
of which n=13 were duplicate titles and were discarded and to n=78 titles retained (53 titles from 
Pubmed/MEDLINE, and 25 titles from Web of Science searches).  After excluding reviews, 
editorials, correspondence, and conference abstracts, a reading of the remaining abstracts -with 
application of inclusion and exclusion criteria- led to 43 abstracts being retained. Careful reading 
of the full-text articles associated to these selected abstracts –and again, applying inclusion and 
exclusion criteria- led to 18 articles being retained. In this step, n=10 articles were excluded 
because it was determined that the studies did not meet inclusion criteria: study outcome did not 
meet inclusion criteria (5), study did not assess externalizing problems in childhood or adolescence 
(1), study did not directly test the hypothesis of interest (2), article written in language other than 
English (2). Fifteen articles were excluded because it was determined studies met one or more 
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exclusion criteria: study based on a selected sample (8), study outcome was a composite score (2), 
study results were not minimally adjusted for age and sex (4), study did not discriminate 
externalizing problems from internalizing problems (1). 
The reference lists of these 18 retained articles were screened for additional articles missed 
by Pubmed/MEDLINE and Web of Science searches, leading to the identification of 2 additional 
articles. Both these articles passed inclusion/exclusion criteria and were therefore selected leading 
to a final set of n=20 articles to be included in this systematic review. 
 
Data extraction 
From each reviewed article the following data was extracted author’s name and year of 
publication, study design (prospective / cross-sectional), study setting (target population, sample 
selection: population-based, clinical sample, convenience sample), sample size, sex composition, 
ages at assessment of exposure and of outcome, method for assessment of exposure (diagnostic 
interview/ parent-teacher questionnaire/ self-reported), the exposure variable, method for 
assessment of outcome (objectively measured / clinical records / self-reported), the outcome 
variable, results (measures of association and corresponding standard deviation or 95% confidence 
intervals, when available; p-values otherwise), stratification or matching procedures, control for 
confounding (detailing variables when available), and study specific advantages and 
disadvantages.  
The information extracted was organized into tables 4.2a and 4.2b, where articles appear 
indexed by study design, and sample size.  
 
Evidence quality grade  
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The quality of the evidence provided by each of the studies reviewed was evaluated based 
on the following system: one point was given for each of: 1) Prospective design (versus cross-
sectional); 2) Sample size > 500; 3) Assessment of externalizing problems based on diagnostic 
interview or by a screening tool with probed construct validity against DSM-IV/V criteria or the 
Achenbach’s Child Behavior Check List; 4) Assessment of outcome by physician-made diagnosis, 
electronic search for physician-made diagnosis recorded in insurance or registrar databases26 or by 
manual review of clinical records27 (versus self reported); and 5) Control for confounding beyond 
age and sex. 
 
Consistency of findings 
Measures of association were classified as indicating elevated (or reduced) risk among the 
exposed if these associations reached statistical significance at 5 % confidence level (Tables 4.1a. 
and 4.1b.).  Measures of association can however be valid but imprecise. Small but otherwise 
sound studies can produce valid effect estimates with confidence intervals that include the null. 
Arbitrarily characterizing such findings as supportive of the null hypothesis (no difference in risk 
between exposed and unexposed) may lead to erroneous conclusions in assessments of consistency 
of findings across studies. Accordingly, consistency of findings is assessed among statistically 
significant findings, but additional tables (Appendix tables A.4.1a. and A.4.1b) were constructed 
to show how consistency changes when non-statistical significant findings from valid studies are 
also considered as supporting elevated risk based on reported effect sizes (within range of effect 





Altogether, the 20 reviewed articles (Tables 4.1a and 4.1b) reported on 40 assessments of 
the relationship between some measure of an externalizing behavior problem/disorder, assessed 
during childhood or adolescence, and one of 10 different endpoints: T2DM or insulin resistance –
indicated by HOMA-IR index- (12 associations examined 4,28-34), blood pressure (14 associations 
examined 28,29,31,33,35-40), subclinical atherosclerosis (3 associations examined 35,41), CVD (1 
association 42 reported), death from CVD (1 association reported 43), endothelial function (3 
associations reported 44-46), unspecified dyslipidemia (1 association reported 29),  total cholesterol 
(3 associations reported 28,33), LDL-cholesterol (1 association reported 33), and triglycerides (1 
association reported 33). 
Twelve 4,28-30,33,35-37,41-44,47of the 20 articles reported on prospective studies, 7 33,34,37-39,45 
reported studies that used cross-sectional designs, and 1 article33 reported on a study that used both 
prospective and cross-sectional designs. The latter is considered in this review either a prospective 
or a cross-sectional study, as it pertains to its different analyses and reports. Overall, 30 of the 43 
associations reported by these 20 articles were assessed using a prospective design. 
All but one42 of the prospective studies were conducted with population-based samples 
from the US, and 6 other countries.  The other study42 was conducted with a clinical sample in the 
US. The sample sizes of prospective studies varied from n=8936 to n=107,84729 and the average 
evidence quality grade (G) among these studies was 3.7, range= 2 to 5. The length of study follow-
up period varied within a range of 3-50 years (mean= 22 years). Three4,36,42 of these studies were 
conducted in male-only, and one in a female-only sample. 
Six of the 9 cross-sectional studies were conducted in population-based samples from the 
US and 4 other countries. The other 2 cross-sectional studies were conducted in clinical samples 
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from the US. Sample size varied across these studies, from n=60 to n=25,812. The average 
evidence quality grade was 3.6, range= 2 to 5. One of these studies was conducted in a female-
only46, and one study was conducted in a male-only sample39. 
Two of the studies 32 40 included in this review, are studies that examined the association 
of an externalizing disorder with a cardiovascular risk factor (or T2DM) with the hypothesis that 
the relationship operates in the direction opposite to that hypothesized in this review. Specifically, 
these studies examined whether hypertension 40 or T2DM 32 are risk factors –as opposed to 
outcomes- of ADHD. Both these studies used cross-sectional designs and used odds ratios as 
measures of association. Because OR outcome = OR exposure, the odds ratio of ADHD between those 
with- and those without hypertension (or T2DM) reported by these studies can likewise be 
interpreted as the odds ratio of hypertension (or T2DM) between those with ADHD and those 
without ADHD and these studies were thus considered suitable for inclusion in this review. Two 
of the articles included in this review examined the relationship between “self-control” in 
childhood with incident T2DM30 or coronary artery calcification41 in adulthood, both using data 
from the Cardiovascular Risk in Young Finns study, and hypothesizing that high self-control 
would have a protective effect. Their measure of self-control –a dimensional score- was derived 
by adding-up reverse coded questions on hyperactivity and aggressive behavior. Their research 
can therefore be seen as examining the protective cardiovascular effects of low externalizing 
problems which, while admittedly not the exact same question that this review investigates, could 
nonetheless provide valid and important evidence if the relationship were one that operated over 
the full dimension of externalizing symptomatology.  
 
Studies that examined T2DM or insulin resistance 
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Eight studies examined T2DM or HOMA-IR as endpoints, altogether assessing 12 
relationships. Of these assessments, 6 (50%) found positive28,29,32-34 and 6 reported no associations 
4,28,30,31. Of the 6 positive associations, 228,29 were observed by studies using a prospective design, 
while all 6 findings of no association were reported by prospective studies. Five of the 12 
assessments, one prospective and 4 cross-sectional, were conducted among children or adolescents 
and all five of them found positive associations.   Only 1 of the 7 studies that assessed outcomes 
in adulthood found a positive association. However, another 34,28 of those assessments in adults 
reported effect estimates consistent with a positive association  (OR: 0.6 (95% CI=0.3,1.7) 
(attention)28, OR: 1.2 (95% CI=0.5,3.0) (hyperactivity)4, OR: 1.4 (95% CI=0.5,4.4)  (conduct 
problems)4) that did not reach statistical significance. Studies that found positive and statistically 
significant associations with T2DM risk reported association estimates in the 2.8-4.1 range28,29,32, 
and those that noted positive associations with HOMA-IR reported effect sizes of about 0.25 unit 
increases in HOMA-IR per 1-sd increase in externalizing problems34 or 0.30 unit increase in girls 
with CBCL-aggressive behavior vs. no aggressive behavior33.  
Overall the quality of evidence was slightly higher among studies that noted positive 
associations among children and adolescents (grade =3.6) than the one study that noted a positive 
association in adults (grade =3.0), or those that noted no associations among adults (grade =3.3). 
The study29 with the best evidence grade (grade=5), a large longitudinal population-based study 
of adolescents found an association of ADHD diagnosis with incident T2DM 3 years later, HR= 
2.8 (95% CI=2.0, 4.1).  In general, studies that reported positive associations used more valid 
methods for assessment of externalizing problems/disorders. Two29,32 of the 6 positive associations 
were observed in studies that relied on physician-diagnosed ADHD and the 4 other were observed 
in studies that employed widely-used screening instruments shown to be reliable and valid across 
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different populations and to be consistent with current clinical criteria for diagnosis of ADHD and 
CD (Achenbach Child Behavior Checklist (CBCL)33 and the Behavior assessment system for 
children, 2nd edition (BASC-2)34), or by psychologists’ direct observation of the children28. On the 
other hand, none of the studies that found no association relied either on clinical diagnoses or any 
screening tools. They relied instead on the now-outdated Rutter’s scales 4,31 –a questionnaire 
developed in the 1960’s that is less consistent with current clinical diagnostic criteria- or on a 
study-developed measure of high self-control without published evidence of construct validity30 
and no evidence of comparability with other more widely-used valid measures.   
Studies that found positive associations were also more likely to have relied on objective 
assessments of outcomes. All 6 positive associations were observed in studies that relied either on 
physician-diagnosed T2DM 29,32 or on assessments of HOMA-IR 33,34. On the other hand, 328,31 of 
the 6 findings of no association were reported by studies that relied on self-reported T2DM, and 
by a fourth study that relied, at least partially, on self-reported T2DM30. Studies reporting positive 
or no-associations with T2DM or HOMA-IR did not clearly differ with regards to sample size or 
confounding control. No discernible trend was seen of particular subdomains of externalizing 
psychopathology being more likely than others to be associated with T2DM or HOMA-IR.   
Although the number of studies is too small to make any conclusive assessments, evidence 
hints that the associations with T2DM or IR might be stronger among girls/women. A study28 that 
investigated the relationship of childhood distress proneness with adult T2DM assessing the 
relationship only among women (not enough diabetes cases arose among the study men) found a 
strong positive association (OR=4.1, 95% CI=1.2, 13.7). In another study33, aggressive behavior 
at age 14 was cross-sectionally associated with higher HOMA-IR among girls only.  
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Studies that examined blood pressure 
Ten studies investigated blood pressure-related endpoints28,29,31,33,35-39, altogether 
examining 14 relationships with: SBP or DBP values (10), Stage II hypertension defined as SBP 
>=160 mmHg, and DBP >=100 mmHg (2), or self-reported hypertension (2). Four28,29,37,39 of these 
14 assessments reported positive associations, 333,40 reported inverse associations, 135 assessment 
found the association to be positive among women and inverse among men, and the other 628,31,36-
38 assessments found no association. Of these 14 analyses, 10 were examined by prospective 
designs28,29,31,33,35-37. Positive, inverse, and no associations were reported in similar fashion by 
prospective and cross-sectional studies.  
Studies that noted positive associations with blood pressure reported a wide range of effect 
sizes: a 1-sd increase in distress proneness at age 7 was associated with a 7-point increase in SBP 
at age 4228, but in another study the highest score of hyperactivity in childhood, versus no 
hyperactivity, was associated with only 0.4 point increase in SBP at ages 24-30 (among women 
only)35. In studies that examined clinically diagnosed hypertension, ORs varied from 1.1329 to 
4.8939, with the smaller effects found for ADHD29 and hyperactivity29 and larger effect sizes found 
for overweight/obese children with family history of hypertension and high Diagnostic Interview 
Schedule for Children (DISC) -delinquent scores39. 
Three33,35 of the 433,35,40 findings of inverse associations of externalizing problems with 
blood pressure were observed among boys or men, and the effect sizes were very small for ADHD 
(OR=0.97, (95% CI=0.96, 0.99)40 and hyperactivity (beta coefficient for SBP: -0.11, p=0.04)35, 
and higher for boys with consistent high CBCL-aggressive scores throughout childhood (2.8 points 
reduction in DBP by age 14, Beta aggressive score x age: -0.02 (95% CI=-0.036, -0.004)33. 
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The quality of evidence from studies that observed positive (grade=3.8) or inverse 
associations (grade=4.0) was better than that from studies that did not find associations (grade= 
3.3). Studies that observed positive and inverse associations with blood pressure were more likely 
to have used a more valid method for assessment of externalizing problems. Physician diagnosis 
of ADHD29, psychologist direct observation of children28, or any of the well-validated Achenbach 
scales  (CBCL or Teacher’s Report Form (TRF)39) were used in in 3 of 5 findings of positive 
associations, in 333,35,40of the 4 findings of inverse associations, but in none of the findings of no 
association.  
No evident differences were found with regards to the quality of assessment of blood 
pressure across studies and no apparent differences were noted across studies that observed 
positive, inverse, or no associations with regards to sample size, except that all the very small 
studies (sample sizes < 200) found either positive or no associations, whereas all studies that 
reported inverse associations used samples with n > 1,000.  
 
Studies that examined blood lipids 
Three independent studies examined blood lipids, altogether assessing 6 associations with 
different endpoints: dyslipidemia (129), triglycerides (133), LDL-Chol (133), and total-Chol (328,33). 
Four of these assessments found positive and statistically significant associations with blood lipids 
(all 4 in children or adolescents)29,33 and the other two (in adults)28 found positive associations 
with similar effect size that did not reach statistical significance. Four of 6 positive associations 
were observed only among boys33 or men28. Dyslipidemia at mean age 18 was associated with 
ADHD at age 13 (OR=2.1, p < 0.001)29, with no reported sex differences. In a cross sectional 
study33 of 14 year olds, each 1-point increase in TRF-aggressive behavior score (range 0-40) was 
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associated with increased total-Chol (Beta: 0.018, 95% CI= 0.003, 0.0320) in boys only, LDL-
Chol (Beta: 0.015, 95% CI= 0.002, 0.027) in boys only, and with triglycerides (Beta: 0.011, 95% 
CI= 0.002, 0.020) in boys and in girls (Beta: 0.013, 95% CI= 0.001, 0.025). In a prospective study 
a 1-sd increase in attention scores at age 7 was associated with a non-statistically significant 
reduction of 5 mg/dl of total-Chol at age 42 among men only (small size, n= 158), and a 1-sd 
increase in distress proneness score predicted a 5 mg/dl non-statistically significant increase in T-
Chol, also among men only28.  Overall, the quality of evidence from these studies that examined 
blood lipids was slightly higher (grade=4.2) than the average quality for all studies (grade=3.6). 
  
Studies that examined other outcomes 
Together, the articles reviewed assessed 8 associations between some externalizing 
problem and one of subclinical atherosclerosis, CVD, or endothelial function, but the number of 
studies per endpoint is very small for reliable inferences to be drawn about any specific outcome.  
Four of the 8 assessments found positive associations, 2 found no associations, and 2 found inverse 
associations. 
The relationship between childhood externalizing problems with subclinical 
atherosclerosis endpoints in adulthood was examined by 2 studies, both using data from the 
Cardiovascular Risk in Young Finns study, a 32-year follow-up study, together examining 3 
different relationships.  One of the studies35 noted a positive association of mid-adulthood c-IMT 
with childhood hyperactivity, an association that was observed only among women. Women in the 
top tertile for childhood hyperactivity showed, on average, an increase of 0.03 mm in c-IMT when 
compared with women in the bottom tertile, an increase that according to the study authors could 
signify a 15% to 20% increase in subsequent CVD risk. In the same study, “negative emotionality”, 
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assessed by a study-developed measure of aggressive-type behavior was not associated with c-
IMT. In the other study41, a 1 standard deviation increase in “self-control” was inversely and 
moderately associated with the presence of coronary artery calcification (OR= 0.59, CI= 0.38, 
0.92), a finding which could be seen also as showing a positive association of moderate size 
between low self-control (an externalizing problem) and coronary artery calcification.  
The association of externalizing problems with CVD endpoints was examined by 2 studies. 
In a long follow-up study with a large sample 43, childhood conduct problems were positively 
associated with a small increase in risk (RR= 1.17, 95% CI= 1.04, 1.32), ) of death from CVD by 
age 65 in men and with a smaller association in women (RR=1.10, 95% CI= 0.92, 1.32). In the 
other study, 42 conducted with a very small clinical sample (n=271), no association was observed 
(OR=1.01) between physician-diagnosed childhood ADHD and self-reported CVD 32 years later. 
Three studies examined endothelial function. Two used data from a study of school 
children in Sweden. Using a cross-sectional design, one of these studies 45 reported an association 
of higher disruptive behavior score with better –not worse- endothelial function at age 14, among 
boys only. The other study44 found a prospective association of higher disruptive behavior score 
at age 14 with worsening endothelial function between ages 14 and 17, also observed only among 
the boys.  The third study that examined endothelial function46 was a very small (n=60) cross-
sectional study in a clinical sample of 15-year old girls. In the study, girls with Conduct Disorder 
appeared to have better endothelial function than control girls. But the quality of evidence of this 
study was low given the small sample size and methodological limitations including no control for 
confounding besides age and sex. 
 
The role of body adiposity in mediating the main associations 
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In all, these articles assessed 40 relationships, finding 22 positive associations. None of the 
studies reviewed conducted any formal assessments of mediation by BMI. Of the 22 reported 
positive associations, 9 had been adjusted for BMI in multiple regression analyses, suggesting that 
the relationships assessed might be at least partially independent of BMI. The remaining 13 
associations were not adjusted for BMI and therefore it is not known whether they too might, to 
any extent, be independent of BMI. One study reported a positive cross-sectional association, 
apparent among girls only, of CBCL-aggressive behavior score with increased HOMA-IR at age 
14 y: among these girls each 1-point increase in the score for aggressive behavior –the score range 
was 36- was associated with a 1% increase in HOMA-IR index. Following simultaneous 
adjustment for BMI and smoking led to a reduction in the size of the association by 60 %.  
 
Developmental timing of the association of externalizing problems with CVD/T2DM risk 
Among the studies reviewed, positive associations with T2DM or HOMA-IR were 
observed in children as young as age 9. No studies examined these endpoints at younger ages. No 
study assessed diabetes or HOMA-IR on more than just one occasion. Positive associations were 
observed by all 5 studies that examined T2DM or HOMA-IR in children or adolescents, however, 
results from studies that tracked participants until adulthood were much less consistent, likely due 
to the fact they tended to rely on less valid and less reliable measures of externalizing problems. 
Not surprisingly, these studies among adults were too more likely to report imprecise estimates of 
association.  Evidence from the studies that found positive associations among adults (statistically 
significant and non-statistically significant) were of better quality than those that did not 
(grade=3.7 vs. grade=3.0).  
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   Overall, the best quality studies found positive associations with T2DM or HOMA-IR 
from late childhood up until mid-adulthood. Childhood externalizing problems were found to be 
positively associated with T2DM or HOMA-IR at ages 932, 1034, 1433, 1829, and 4228. 
Blood pressure related endpoints were examined by these studies in children as young as 
age 839. Three studies that assessed blood pressure before age 15 found inverse small associations 
33,40 and two found no association36,38. Among studies that assessed blood pressure in young and 
mid-adulthood, the 2 studies that examined the relationship with childhood attention/inattention 
found no association28,37, but all 4 studies that examined hyperactivity or aggressive behaviors 
found positive associations with SBP  (mmHg) at ages 24-3035 and 4228 years, and with diagnosed 
HTN at ages 1829 and 2937 years. It is unclear from the studies reviewed whether the inverse 
association with blood pressure observed (mostly among boys) before age 15 is one that persists 
into later developmental stages for at least some individuals.  
The association of externalizing problems with blood lipids was examined and was found 
to be positive at ages 1433, 1829 and 4228. None of the studies evaluated blood lipids before age 14. 
Endothelial function was only assessed during adolescence and the best quality evidence showed 
a positive (worsening function) association44. Subclinical atherosclerosis was assessed only in 





This systematic review summarized and evaluated the consistency in the existing literature 
on the relationship of externalizing problems/disorders experienced in childhood and adolescence 
with CVD/T2DM risk. The developmental period at which the associations become observable, 
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whether they persist into adulthood, and whether they are independent of the already known 
positive association of externalizing problems with body adiposity, were additional questions of 
interest. 
Overall, and despite great methodological heterogeneity among studies, this review found 
consistent evidence of a positive association between externalizing problems with increased risk 
for CVD and T2DM. Although several studies found no evidence of associations, studies that used 
more valid methods consistently did. Current evidence is particularly solid for associations with 
T2DM risk (particularly among children/adolescents, and stronger among girls and women) and 
blood lipids (stronger among boys/men). Based on more limited evidence, the studies also support 
relationships with subclinical atherosclerosis and worsening endothelial function. Associations 
were found for clinical diagnosis of ADHD as well as for subclinical and dimensional measures 
of aggressive behavior, conduct problems, hyperactivity and impulsivity, low self-control, and low 
attention symptomatology.  
This review also found evidence that these associations emerge as early as late childhood, 
and they are evident by mid-adolescence for a wide range of CVD/T2DM related endpoints: 
T2DM, HOMA-IR, endothelial function, total-Chol, LDL-Chol, and triglycerides. We also found 
that externalizing problems are likely not associated with increased blood pressure until late 
adolescence or mid-adulthood, and that high blood pressure might result from hyperactivity and 
conduct problems but not from attention problems. 
 
Evidence also suggests that the positive associations with CVD/T2DM operate in part 
independently of BMI. Although adjusting regression models for BMI would not be appropriate 
to assess mediation in the presence of exposure-mediator interactions and none of the studies 
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showed evidence that such interactions were not present, the fact that associations persisted in 8 
of the 9 instances in which BMI was adjusted for, indicates that some proportion of the associations 
operate through mechanisms not involving BMI. As total and adjusted effect sizes were not 
separately reported in these studies it is not possible to approximate (even informally) the relative 
magnitude of this direct effect not mediated by BMI.  
Stress-related psychopathology, including externalizing psychopathology, is thought to 
influence CVD/T2DM risk through SNS/HPA-mediated neuroendocrine effects and/or by its 
association with unhealthy behaviors. Sustained stress experienced during particularly sensitive 
developmental periods could be especially deleterious 48,49. The nervous, endocrine, and immune 
systems undergo critical maturation throughout childhood 50 and it is possible that stress-related 
psychopathology in early life could act as a modifying factor in the maturation process of these 
systems becoming embedded in a lasting fashion, with long life effects and vulnerability to chronic 
disease. Poor health behaviors known to influence CVD/T2DM are also known to be established 
before adulthood and to be stubborn to later modification. 
The precise nature of the mechanisms involved in mediating the effects of externalizing 
problems on CVD/T2DM risk -as well as the relative contribution by different mechanisms- might 
not be constant over the life-course due to the existence of sensitive developmental periods and/or 
due to changes in the exposure to unfavorable health behaviors throughout developmental stages. 
For instance, high intake of sugar-sweetened beverages might be a key mediator in childhood, but 
smoking may be a more important one in late adolescence. The relative importance of pathways 
may also vary across populations with different prevalence of obesity, smoking, and other health 
behaviors. 
		 	152	
Unlike internalizing problems (including depression and anxiety) which have been 
consistently linked to an overactive SNS-HPA axis, externalizing problems have also been 
associated with sympathetic underarousal, with lower basal cortisol, and blunted cortisol 
response51,52. Hypocortisolism is, in turn, associated with decreased heart rate and hypotension. 
This observation would be at odds with the model described above to explain positive effects on 
CVD/T2DM risk, but it would provide a basis for the small inverse association of externalizing 
measures with lower blood pressure in children observed by a couple of methodological sound 
studies in this review. It has been observed that sympathetic underarousal and low cortisol profiles 
are specifically observed among more delinquent or severe cases of conduct disorder52, less so in 
community samples51.  Indeed, in this review, an inverse association with blood pressure was 
reported for children with aggressive behavior scores consistently above the 95th percentile 
throughout childhood and adolescence versus children with low score33. In community samples, 
however, children with comorbid anxiety and conduct problems were shown to have higher –not 
suppressed- levels of cortisol51. Internalizing-externalizing comorbidity is highly prevalent so 
community-based studies might find different results regarding blood pressure depending on the 
prevalence of externalizing-internalizing comorbidity and on whether studies recruited and 
retained participants with more severe behavior problems. None of the studies included in this 
review examined SNA/HPA activation/attenuation effects in relationship to externalizing (or 





This systematic review has some limitations. First, overall, the literature on childhood 
externalizing problems and CVD/T2DM is small and is heavily focused on diabetes and blood 
pressure. Few articles investigated other clinically relevant outcomes including blood lipids, 
atherosclerosis, and endothelial function.  I searched two of the most comprehensive electronic 
databases, but it is still possible that coverage of the existing literature by these databases was not 
complete and therefore that some relevant articles were missed. Second, a second reviewer was 
not used in the literature search process and it is possible that the final list of articles would have 
been slightly different had there been one additional reviewer. 
Third, articles were chosen for inclusion based on whether they examined one (or more) of 
a pre-defined set of CVD/T2DM-related outcomes known to be causally associated with heart 
disease, stroke, and T2DM, and considered relevant to CVD/T2DM risk in clinical practice. This 
list was not exhaustive, however, with regards to all biological parameters known to relate with 
the functioning of the cardiovascular and metabolic systems and therefore research that examined 
relationships with such outcomes not currently employed in the risk screening in clinical practice 
not was not covered by this review (i.e. resting heart rate). Lastly, only-English written articles 
were included, and it is possible that results would have been somehow different without this 




The current literature is both scarce and limited by a range of methodological 
shortcomings. Future studies should strictly rely on the use of well-validated measures of 
externalizing symptomatology or diagnoses, objective assessments of CVD/T2DM risk, and 
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employ prospective designs, ideally - in particular for studies with short follow up - relying on 
both baseline and end-of-study assessments of study outcomes.  
 
The use of multiple informants of externalizing behavior has been shown to increase validity of 
assessments, and external informants –as opposed to self- are known to be particularly more valid 
for assessment of externalizing psychopathology53. Only a few of the reviewed studies relied on 
more than one informant but those that did, and especially those that included reports from parents 
and teachers were more likely to observe positive associations. 
The assessment of CVD/T2DM risk among children is currently handicapped by the fact 
that normative data has not yet been established for this age population making it difficult to 
evaluate the clinical significance for CVD/T2DM risk of small increments in the values of 
parameters such as HOMA-IR, blood lipids, and blood pressure. Furthermore, studies in this 
review that assessed peripheral endothelial function among adolescents by measuring a reactive 
hyperemia index relied on algorithms developed for adult populations and it is unclear how 
findings would differ with more age-appropriate assessments. 
Control for confounding was in general insufficient and few studies adjusted for factors 
other than basic demographics. Family history of psychiatric diseases – including maternal 
depression -, diabetes, and cardiovascular disorders are all associated with externalizing 
psychopathology and with CVD risk therefore failing to adjust for these factors may likely bias 
effect sizes against the null. Pregnancy and birth outcomes are additional likely confounders not 
accounted for in any of the studies reviewed. Common genetic and/or neurobiological 
vulnerabilities could, in addition, be an alternative explanation for the relationships examined in 
this review but no research has investigated these pathways yet.   
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Phenotypic distinctions within externalizing psychopathology, such as inattention, 
hyperactivity, impulsivity, and aggression, may have critical bearings on risk for certain outcomes 
or might have unique developmental sensitive points but very few studies examined these 
subdomains separately. The very few that did suggested not only that these differences may indeed 
exist but showed, in addition, that these differences may also interact with sex. Relatedly, 
internalizing and externalizing comorbidity is another aspect that studies should consider given 
the conflicting evidence on the roles of externalizing and internalizing psychopathology in 
activation/attenuation of the SNP/HPA axis and also in their possibly differing relationships with 
health behaviors and coping mechanisms throughout developmental stages and across the sexes. 
For example, while externalizing behaviors in childhood are associated with earlier initiation of 
smoking, withdrawal and anxiety are associated with delayed initiation. Two of the studies 
included in this review also examined the role internalizing problems and their results support 
opposite conclusions. In one of them, a cross-sectional assessment34 of children aged 9-12y, 
BASC-2 externalizing problems (but not BASC-2 internalizing problems) were associated with 
higher HOMA-IR. But, in a very small study46 of 15-year old girls, n=60, girls with “Conduct 




This systematic review of the literature found evidence of a positive association between 
childhood and adolescence externalizing problems with increased risk for CVD and T2DM. 
Children with externalizing problems appear to have increased risk of developing T2DM, and to 
have unhealthy levels of blood lipids. Based on more limited evidence and mixed findings, they 
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might also have worse endothelial function and subclinical atherosclerosis. CVD and T2DM risk 
appear to be already elevated among children with externalizing problems before adolescence. The 
evidence suggests, in addition, that externalizing problems influence CVD/T2DM risk at least in 
part independently of their effect on BMI. These results show that long physical disease burden 
associated with externalizing psychopathology might be greater than thought, that strategies that 
target excess body weight may be insufficient to address physical health problems among these 
children, and that CVD/T2DM risk monitoring might need to be extended to non-obese children 
with externalizing problems. Much research is needed to confirm findings, including prospective 
studies in children and adolescents that employ well-validated measures for assessment of clinical 
and subclinical symptoms that distinguish hyperactive, inattentive, and other externalizing 
problem subtypes. Studies that can also account for internalizing/externalizing/sex interactions 
would be particularly informative and especially so if they examined differential associations with 
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Table 4.1. a: Summary of all findings reported by studies in review, by study outcome 
 
 
Outcome Associations with 
the outcome tested 
 
Risk of outcome was 
elevated among the 
exposed* 
Risk of outcome was the 
same among exposed and 
unexposed 
Risk of outcome was 
reduced among the 
exposed* 
 
 N Average G % (n/N) Average G % (n/N) Average G % (n/N) Average G 
T2DM / HOMA-
IR 
12 3.4 60 (6/12) 3.5 40 (6/12) 3.3 -- -- 
Blood pressure 14 3.6 36 (5/14) 3.8 43 (6/14) 3.3 21 (3/14) 4.0 
Subclinical 
atherosclerosis 
3 3.3 67 (2/3) 3.0 33 (1/3) 4.0 -- -- 
Endothelial 
function 
3 3.3 33 (1/3) 4.0 -- -- 67 (2/3) 3.0 
Blood lipids 6 4.2 67 (4/6) 4.3 33 (2/6) 4.0 -- -- 
G= Evidence quality grade (range 0-5) 
 
*Associations are statistically significant 
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Table 4.1. b: Summary of study findings, by timing of outcome assessment (childhood/adolescence or adulthood) and by study 
outcome 
 
Outcome Associations with 
the outcome tested 
 
Risk of outcome was 
elevated among the 
exposed* 
Risk of outcome was the 
same among exposed and 
unexposed 
Risk of outcome was 
reduced among the 
exposed* 
 N Average G % (n/N) Average G % (n/N) Average G % (n/N) Average G 
 Studies that assessed outcomes in childhood or adolescence 
T2DM / HOMA-
IR 
5 3.6 100 (5/5) 3.6 -- -- -- -- 
Blood pressure 7 3.6 29 (2/7) 4.0 29 (2/7) 2.5 43 (3/7) 4.0 
Subclinical 
atherosclerosis 
0 -- -- -- -- -- -- -- 
Endothelial 
function 
3 3.3 33 (1/3) 4.0 -- -- 67 (2/3) 3.0 
Blood lipids 4 4.3 100 (4/4) 4.3 -- -- -- -- 





7 3.6 14 (1/7) 3.0 71 (6/7) 3.3 -- -- 
Blood pressure 7 3.7 43 (3/7) 4.0 57 (4/7) 3.5 -- -- 
Subclinical 
atherosclerosis 
3 3.3 67 (2/3) 3.0 33 (1/3) 4.0 -- -- 
Endothelial 
function 
0 -- -- -- -- -- -- -- 
Blood lipids 2 4 -- -- 100 (2/2) 4.0 -- -- 
G= Evidence quality grade (range 0-5) 
 
*Associations are statistically significant 
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Louise,	S	 Population-based.	 N=757-1697,	 Multi-informant	 CBCL	aggressive	 Systolic	and	diastolic	blood	 Continuous	 In	linear	regression	 Sex	stratifie Association	 Population	based,	use	 4	
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*Evidence pertaining to SBP and blood lipids, each objectively assessed by study was graded G=4.  Evidence pertaining to self-
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Risk	of	outcome	was	reduced	among	the	exposed			 N	 Average	G	 %	(n/N)	 Average	G	 %	(n/N)	 Average	G	 %	(n/N)	 Average	G	T2DM	/	HOMA-IR	 12	 3.4	 75	(9/12)*	 3.6	 25	(3/12)	 2.9	 --	 --	Blood	pressure	 14	 3.6	 36	(5/14)	 3.8	 43	(6/14)	 3.3	 21	(3/14)	 4.0	Subclinical	atherosclerosis	 3	 3.3	 67	(2/3)	 3.0	 33	(1/3)	 4.0	 --	 --	Endothelial	function	 3	 3.3	 33	(1/3)	 4.0	 --	 --	 67	(2/3)	 3.0	Blood	lipids	 6	 4.2	 100	(6/6)**	 4.2	 --	 --	 --	 --	
G= Evidence quality grade (range 0-5) 
 
* Includes 3 non-statistically significant associations 
 





Table A.4.1b: Summary of associations reported by studies, by timing of outcome 





	 N	 Average	G	 %	(n/N)	 Average	G	 %	(n/N)	 Average	G	 %	(n/N)	 Average	G		 Studies	that	assessed	outcomes	in	childhood	or	adolescence	T2DM	/	HOMA-IR	 5	 3.6	 100	(5/5)	 3.6	 --	 --	 --	 --	Blood	pressure	 7	 3.6	 29	(2/7)	 4.0	 29	(2/7)	 2.5	 43	(3/7)	 4.0	Subclinical	atherosclerosis	 0	 --	 --	 --	 --	 --	 --	 --	Endothelial	function	 3	 3.3	 33	(1/3)	 4.0	 --	 --	 67	(2/3)	 3.0	Blood	lipids	 4	 4.3	 100	(4/4)	 4.3	 --	 --	 --	 --		 Studies	that	assessed	outcomes	in	adulthood	T2DM	/	HOMA-IR	 7	 3.6	 57	(4/7)*	 3.5	 43	(3/7)	 2.9	 --	 --	Blood	pressure	 7	 3.7	 43	(3/7)	 4.0	 57	(4/7)	 3.5	 --	 --	Subclinical	atherosclerosis	 3	 3.3	 67	(2/3)	 3.0	 33	(1/3)	 4.0	 --	 --	Endothelial	function	 0	 --	 --	 --	 --	 --	 --	 --	
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Blood	lipids	 2	 4	 100		(2/2)**	 4.0	 --	 --	 --	 --	
Table A.4.1b Cont’d 
 
G= Evidence quality grade (range 0-5) 
 
* Includes 3 non-statistically significant associations 
 







Table A.4.1b Cont’d 
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Figure A.4. 1: Pubmed/Medline Search terms 
 
Search ((((((((((((attention deficit and disruptive behavior disorder)) OR child attention 
problems) OR child inattention) OR hyperactivity problems) OR (attention deficit and 
hyperactivity problems)) OR conduct disorder) OR child conduct problems) OR 
externalizing behavior problems) OR externalizing disorders) OR child behavior 
problems)) AND ((((((((((cardiovascular diseases) OR hypertension) OR blood pressure) 
OR insulin resistance) OR hyperglycemia) OR hyperinsulinemia) OR diabetes mellitus, 
type 2) OR atherosclerosis) OR cholesterol) OR triglycerides) Sort by: Best 










Research conducted over the last decade has unveiled a positive association of internalizing 
problems, including anxiety and mood disorders, with the development and worsening of 
cardiometabolic disorders among adults 1-3.  Current knowledge suggests that the relationship is 
one likely to be established in early life, and also that common externalizing problems such as 
hyperactivity, conduct, and attention problems may too contribute to increase the risk for 
cardiovascular diseases and T2DM. These disorders and its biological precursors, once considered 
diseases of the old, are now increasingly diagnosed among the young4-6. Currently, only a fraction 
of CVD/T2DM can be explained by known risk factors and the identification of new ones, 
especially early-life risk factors, is an explicit top priority in public health research4,7,8. Very little 
studies have examined these questions. This dissertation sought to shed light into these important 
matters. 
 
Summary of findings:  
 
Chapter 2 of this dissertation describes research conducted to examine the prospective 
relationships between childhood internalizing and externalizing problems with clinically 
significant high levels of 3 biological markers known to be causally associated with CVD and 
T2DM development: HOMA-Insulin Resistance index, LDL-Cholesterol, and Triglycerides. 
These relationships were investigated using data from a large, population based cohort study 
(ALSPAC) assembled in the UK in the years 1990/2 9,10. Findings showed that children with 
externalizing problems (hyperactivity problems or conduct problems) have higher risk of 
developing high levels of HOMA-IR (insulin resistance) and blood triglycerides at age 17. These 
children were also more likely to be obese by age 15. On the other hand, this research found that 
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compared to other children, children with internalizing problems (emotional problems) had 
decreased risk of developing high levels of triglycerides by age 17 and were also less likely to be 
obese at age 15. These associations persisted after comprehensive adjustment for confounding by 
demographic, socioeconomic, maternal and environmental factors, family history of CVD and 
T2DM, pregnancy and birth outcomes, breastfeeding and after controlling for study attrition bias. 
Associations also persisted when hyperactivity, conduct, problems, and emotional problems were 
adjusted for each other. The associations of childhood hyperactivity and conduct problems with 
higher HOMA-IR and with clinically significant high triglyceride values that this research found 
are novel as no prior studies investigated these questions prospectively in a cohort of healthy 
children. But these results are consistent with findings from two prior studies that showed an 
association of ADHD at age 13 with incident T2DM and prevalent dyslipidemia at age 1811 and 
with cross-sectional associations of aggressive behavior at age 14 with triglycerides (among boys 
and girls) and with HOMA-IR (among girls only)12. Control for confounding was minimal in both 
these studies, limited to basic demographics. This dissertation’s research adds to knowledge from 
prior studies in three ways: first, it shows that increased CVD and T2DM   risk in adolescence is 
already predicted by childhood (as opposed to adolescence) levels of hyperactivity and conduct 
problems; second, it shows the first evidence to date of a prospective positive association of 
externalizing problems with clinically significant levels of triglycerides in adolescence; third, it 
reports effect estimates that are adjusted for a comprehensive set of confounding factors and that 
are, therefore, less biased than effects estimates reported by prior studies; and fourth, it shows for 
the first time in the same report that externalizing and internalizing problems are differentially 
associated with CVD/T2DM in children and adolescents. This dissertation’s findings of inverse 
associations of internalizing problems with obesity are consistent with some prior findings of 
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similar relationships of depressive symptoms with obesity in children13,14 but it extends that 
knowledge by providing the first evidence of a prospective inverse association with clinically 
significant values of triglyceride that persisted to robust adjustment for confounding. 
Chapter 3 describes research conducted to elucidate the mechanism/s underlying the 
positive associations identified in Chapter 2 of childhood hyperactivity and conduct problems with 
clinically significant high levels of triglycerides at age 17. Causal mediation methods15,16 that 
account for the partial overlapping of mediation pathways by several mediators were used to 
determine the extent to which the effects of hyperactivity and conduct disorder were explained, or 
mediated, by a series of potential mediators.  Specific potential mediators were selected based on 
the current literature as factors that have been linked to both, externalizing symptomatology and 
increased levels of triglycerides and included:  hours of sleep17, aspects of diet18,19, physical 
activity20, consumption of alcohol21, smoking21, body mass index and changes of body mass 
index22.  Analyses found relatively low prevalence in the sample of some of the mediators tested, 
compared with US cohorts23, and more recent UK cohorts24. Hyperactivity and conduct problems 
were strongly associated with some (BMI, sleep hours, SSB) but not all (alcohol, smoking) of the 
mediators tested.  Triglyceride levels were weakly associated with a few of the mediators 
(smoking, alcohol, dietary fat composition) and was only strongly associated with BMI. Causal 
mediation analyses found that the associations of childhood hyperactivity and conduct problems 
with clinically triglycerides at age 17 are mostly explained by direct effects, that is, effects are 
largely not mediated by the factors considered. Specifically, it was estimated that, at most, 20 % 
of the total effects of hyperactivity and conduct problems on triglycerides were explained by 
pathways involving these specific mediators, and the mediated effects were largely accounted for 
by body mass index. These findings are supported by a strong study design and methodology and 
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they are relevant given that no other studies have conducted formal assessment of mediation of 
these relationships.  Our results are consistent with findings of relationships persisting after 
regression adjustment for BMI in a few studies that found associations of aggressive behavior with 
HOMA-IR12, and of ADHD with T2DM and dyslipidemia 11.  
Chapter 4 describes research conducted to summarize and assess consistency of the 
current literature that investigates the relationship of childhood externalizing problems with 
increased CVD/T2DM risk over the life course. The developmental timing (i.e. childhood, 
adolescence, young adulthood, mid-adulthood, older adulthood) at which elevation of risk 
becomes evident and whether the relationships are mediated by increased body adiposity were 
additional questions of interest. A systematic review of the literature was conducted following 
PRISMA guidelines.   A search of 2 electronic databases (Pubmed/Medline and Web of Science) 
led to the identification, and selection (based on pre-defined inclusion and exclusion criteria) of 
20 original research reports. Studies were graded for quality of evidence. This systematic review 
found solid evidence, based both on consistency of reports and quality of evidence, of a positive 
association of externalizing problems with increased risk of T2DM and with elevated levels of 
HOMA-IR in childhood and adolescence. This evidence came mostly from cross-sectional studies. 
Evidence was equally solid, and again, mostly cross-sectional, in support of an association with 
higher levels of blood lipids (T-Cholesterol, LDL-Cholesterol, and triglycerides) in adolescence. 
Evidence that these effects may persist into adulthood was less clear, possibly owing to the fact 
that prospective studies that tracked individuals into adulthood were of lower quality, with a 
tendency to rely on less valid externalizing assessment methods and on self-reports of T2DM and 
CVD related outcomes.  This review found also some evidence of positive associations with 
outcomes other than T2DM or blood lipids, including prospective worsening endothelial function 
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(in adolescence) and prospective subclinical atherosclerosis (mid-adulthood) but research on those 
outcomes was too sparse for an assessment of consistency. Although no study applied formal 
assessments of mediation, evidence from regression analyses suggests that positive associations 
were independent of body adiposity. 
In summary, together, the results from the empirical research (Chapters 2 and 3) and the 
literature review (Chapter 4) support a longitudinal association of childhood hyperactivity and 
conduct problems with increased risk of T2DM, elevated HOMA-IR and clinically significant high 
levels of blood lipids in adolescence. Our findings suggest that these effects are to a large extent 
independent of body adiposity and unfavorable health behaviors. 
 
Implications of findings 
 
The findings in this research have implications at various levels. First, externalizing 
problems are identified as a novel childhood risk factor for early development of CVD/T2DM risk, 
directly addressing a current priority of public health research while also providing newer support 
to hypotheses of the childhood origins of chronic diseases. Second, these results add to the 
evidence that physical health is impaired in children with externalizing problems and suggest that 
CVD/T2DM risk –specifically, HOMA-IR and blood lipids- might need to be monitored in 
adolescents with a history of externalizing problems.  Third, findings that CVD/T2DM risk is 
elevated in adolescents with a history of childhood behavior problems regardless of body adiposity 
and poor health behaviors suggests that current guidelines for monitoring of cardiometabolic risk 
may not be adequate and that risk should be monitored in all children with externalizing problems, 
not just obese or at-risk of obesity adolescents. Furthermore, if confirmed by future studies, this 
		
 	 223		
research also suggests that lifestyle modification approaches might not be enough to reduce CVD 
and T2DM risk among these children. Fourth, this research may also contribute to expand 
understanding of the processes of biological embedding of mental health problems. That childhood 
externalizing, but not internalizing behavior problems, are associated with CVD and T2DM mainly 
through pathways that do not involve adiposity or health behaviors may suggest of relevant 
neurobiological differences between these two overarching domains of psychopathology. 
Proposed alternative pathways include pro-inflammatory and pro-insulinemic effects triggered by 
stress-related disruption of the SNS-HPA axis in psychopathology. Research on how internalizing 
and externalizing psychopathology, both associated with greater stress, differ with regards to those 




Future research studies should seek to replicate these findings and to further expand this 
newly gained knowledge. This research supports a number of recommendations for next studies.  
First, studies should ideally be conducted in more recent cohorts known to bear higher 
prevalence of obesity and unhealthy health behaviors.   
Second, studies should strictly rely on the use of well-validated measures of externalizing 
symptomatology or diagnoses, objective assessments of CVD/T2DM risk, and employ prospective 
designs, ideally - in particular for studies with short follow up - relying on both baseline and end-
of-study assessments of study outcomes. In fact, research is critically needed to obtain normative 
data on cardiometabolic risk parameters in children. The use of multiple informants of 
externalizing behavior has been shown to increase validity of assessments, and external informants 
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–as opposed to self- are known to be particularly more valid for assessment of externalizing 
psychopathology25.  
Third, studies should also examine whether CVD and T2DM risk varies among adolescents 
with childhood-limited, adolescence-onset, and childhood-onset persistent externalizing problems, 
and whether different phenotypic sub-types including, inattentive, hyperactive, and more 
antisocial types, may have critical bearings on risk for certain outcomes or might have unique 
developmental sensitive points. Research from the very few studies that have done so (among 
adults) supports the existence of these differences and further suggest that differences might vary 
by sex/gender26,27. Future studies should include measures that allow the characterization of these 
subtypes using stratified sampling approaches to ensure adequate power to study these 
relationships.  
Fourth, more research is needed into the mechanisms that underlie the relationships 
elucidated by this research. Perhaps more refined hypothesis are needed with regards to health 
behaviors. For example, sleep anomalies other than short sleep hours may be involved. Approaches 
for dietary assessments that overcome participants misreporting problems are needed. 
Furthermore, future studies that follow children across developmental stages should assess health 
behavior mediators on more than one occasion as habits are likely to change throughout follow-
up, in part just due to normative effects.  
Fifth, these findings support expanded research into the role of SNS-HPA axis disruption 
in mediating the relationships reported here. Sixth, studies should seek to measure and control for 
confounding other than basic demographics. Our research in Chapters 2 and 3 could be used as a 
guide for that manner. Family history of psychiatric diseases – including maternal depression -, 
diabetes, and cardiovascular disorders are all associated with externalizing psychopathology and 
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with CVD risk therefore failing to adjust for these factors may likely bias effect sizes against the 
null. Pregnancy and birth outcome are additional likely confounders that this dissertation research 
accounted for, but not by any prior studies. Common genetic and/or neurobiological vulnerabilities 
could, in addition, be an alternative explanation (confounding) for the relationships examined in 
this review. Future research should investigate these relationships as well.   
Lastly, internalizing and externalizing comorbidity is another key aspect that studies should 
consider, given that comorbidity is highly prevalent, given that, externalizing and internalizing 
problems seem to exert opposite effects on obesity and triglycerides (at least until adolescence) as 
we report, and given the known differing relationships of internalizing and externalizing problems 
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